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Cardiac morphogenesis and skeletal muscle morphogenesis are critical 
developmental processes that require ongoing coordination and signaling 
between cells and the matrix of their surrounding environment.  The 
extracellular matrix (ECM) itself is a complex and dynamic structure whose 
regulation is of the utmost importance to cell behavior.  While it is well 
characterized that the ECM is essential for organogenesis, it is less known 
how ECM composition informs development.  Here, we show that the 
transmembrane protein Tmem2 is an essential regulator of ECM organization 
during cardiac and skeletal muscle morphogenesis.  In zebrafish, maternal 
and zygotic depletion of tmem2 renders embryos unable to form primitive 
heart tubes, whereas in muscle tissue this same loss results in destabilization 
of muscle fibers.  In contrast, zygotic loss of tmem2 results in ectopic 
atrioventricular canal (AVC) differentiation.  All three of these striking 
phenotypes are accompanied by disorganized and defective ECM deposition, 
reflecting an important role for Tmem2 in regulation of the extracellular 
environments that impact development.  The molecular mechanism of Tmem2 
function, however, is unclear.  Our results identify the structural requirements 
for Tmem2 activity across multiple developmental roles.  Further, our studies 
characterize disorganization of the ECM in tmem2 mutants.  Finally, our 
findings support the model that Tmem2 directly influences ECM structure and 
composition in a context-dependent manner, while maintaining the possibility 
that Tmem2 can have additional mechanisms of activity.
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Chapter 1: Mechanisms of cardiac and skeletal muscle morphogenesis  
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Overview: The role of Tmem2 in cardiac and skeletal muscle 
morphogenesis  
 In this chapter, I will summarize the morphogenetic processes that form 
the heart and skeletal muscle.  I will also discuss what is known about how the 
extracellular matrix (ECM) influences each tissue during its development.  
Finally, I will examine the role of Tmem2 in each context.  I have chosen to 
present these processes in the order in which they occur during development.  
First, I will discuss formation of the primitive heart tube.  Next, I will review 
muscle fiber formation and attachment.  After that, I will discuss the formation 
of the atrioventricular canal (AVC) within the heart.  Last, I will discuss what is 
known about Tmem2 function, as well as a more detailed analysis of Tmem2 
structure. 
 
The primitive heart tube forms through cardiac fusion 
In all vertebrates, cardiac morphogenesis occurs through the dynamic, 
collaborative motion of a community of cells (Brade et al., 2013; Brand, 2003; 
Fishman and Chien, 1997; Glickman and Yelon, 2002; Harvey, 2002; Miquerol 
and Kelly, 2013; Moorman and Christoffels, 2003; Moreno-Rodriguez et al., 
2006; Schleich et al., 2013).  First, bilateral populations of cardiomyocytes 
migrate toward the embryonic midline (Fig. 1.1A) (Bakkers et al., 2009; 
Dunwoodie, 2007; Glickman and Yelon, 2002; Harvey, 2002; Moorman and 
Christoffels, 2003).  There, the two groups of cardiomyocytes meet and merge 
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through a process called cardiac fusion and assemble a myocardial cylinder 
(Fig. 1.1B,C) (Bussmann et al., 2007; Evans et al., 2010; Holtzman et al., 
2007; Moreno-Rodriguez et al., 2006).  The primitive heart tube is remodeled 
into two morphologically distinct chambers at later stages (Fig. 1.1D).  While 
the stages of cardiac morphogenesis have been well described, the precise 
mechanisms driving these events remain poorly understood.  Thus, the 
process of cardiac fusion provides a tractable opportunity to investigate the 
genetic pathways regulating cardiac cell behavior.   
Mutations that disrupt cardiac fusion have revealed that the 
environment surrounding the cardiomyocytes has a significant influence on 
these processes.  In particular, interaction between the myocardium and the 
adjacent endoderm influences cell movement.  Mutations in both mouse and 
zebrafish that impact endoderm specification or integrity likewise inhibit 
cardiac fusion (Alexander et al., 1999; Holtzman et al., 2007; Kawahara et al., 
2009; Kikuchi et al., 2001; Kupperman et al., 2000; Li et al., 2004; Mendelson 
et al., 2015; Molkentin et al., 1997; Osborne et al., 2008; Ragkousi et al., 
2011; Ye and Lin, 2013; Yelon et al., 1999).  Although studies in chick suggest 
that endodermal contraction physically pulls myocardial cells medially 
(Aleksandrova et al., 2015; Cui et al., 2009; Varner and Taber, 2012), the 
force exerted by endodermal tissue seems insufficient for the entirety of 
myocardial displacement during cardiac fusion (Aleksandrova et al., 2015; Cui 
et al., 2009; Varner and Taber, 2012; Xie et al., 2016; Ye et al., 2015).  Recent 
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work from our lab has revealed the importance of PDGF signaling between the 
endoderm and myocardium in directing cardiomyocyte migration toward the 
embryonic midline (Bloomekatz et al., 2017).  In zebrafish, mutation of pdgfra, 
a gene encoding the PDGF receptor, results in misdirection of cardiomyocyte 
trajectories during cardiac fusion.  Importantly, it was also shown that pdgfaa, 
a PDGF ligand, is expressed in the endoderm and that ectopic expression of 
pdgfaa interfered with cardiac fusion.  Thus, these results suggest an 
instructive role for PDGF signaling between the endoderm and the 
myocardium that promotes cardiac fusion.   
While it is clear that the endoderm plays a critical role in cardiac cell 
movement, there are additional factors influencing the cell behaviors that 
initiate heart tube formation.  Studies of zebrafish mutations that disrupt 
cardiac fusion have revealed the extracellular matrix (ECM) as another key 
regulator of cardiomyocyte movement (Arrington and Yost, 2009; Garavito-
Aguilar et al., 2010; George et al., 1997; Linask and Lash, 1988; Trinh and 
Stainier, 2004; Trinh et al., 2005).  Either excessive or depleted ECM 
deposition impacts myocardial movement toward the midline.  For instance, 
excessive fibronectin (Fn) in zebrafish hand2 (han) mutants and deficient Fn 
deposition in zebrafish fn1/natter (nat) mutants have both been shown to 
impede cardiac fusion (Fig. 1.2) (Garavito-Aguilar et al., 2010; Trinh and 
Stainier, 2004; Trinh et al., 2005).  Further, the fusion defect in han mutants 
can be rescued through nat loss-of-function, suggesting that a precise 
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composition of ECM is necessary for optimal cardiomyocyte motility (Fig. 1.2F) 
(Garavito-Aguilar et al., 2010).  Although correct ECM deposition is thought to 
be integral for cardiac fusion, the factors that insure appropriate ECM 
organization in this context remain unknown.   
 
Tmem2 promotes cardiac fusion 
Our studies of Tmem2 originated with an intriguing mutation that 
emerged from our laboratory's ongoing forward genetic screens (Auman et al., 
2007).  This zygotic recessive lethal mutation was first identified because of its 
effects on ventricular morphology and atrioventricular canal formation (Totong 
et al., 2011).  Interestingly, generation of maternal-zygotic tmem2 (MZtmem2) 
mutants, in which both maternal and zygotic supplies of tmem2 are depleted, 
revealed an additional, earlier function of tmem2 during cardiac fusion (Totong 
et al., 2011).  In contrast to maternal tmem2 (Mtmem2) mutants, which are 
indistinguishable from wild-type embryos, the cardiomyocytes in MZtmem2 
mutants do not migrate normally and instead remain bilateral to the midline 
(Fig. 1.3A,B), ultimately forming separate hearts in lateral positions, a 
condition known as cardia bifida (Fig. 1.3E, F).  In addition, endocardial cells 
that build the vascular lining of the heart tube fail to fuse in MZtmem2 mutants 
(Fig. 1.3C,D) (Totong et al., 2011).  Thus, Tmem2 plays a crucial role in 
promoting both myocardial and endocardial fusion.  
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Does Tmem2 function within cardiomyocytes, the environment through 
which these cells travel, or both?  Transgenic tissue-specific rescue 
experiments in MZtmem2 mutant embryos yielded some insight into this 
question.  Transgenic overexpression of tmem2 in the myocardium is sufficient 
to induce cardiomyocyte movement in MZtmem2 mutants (Fig. 1.4A-D) 
(Totong et al., 2011).  Although morphogenesis is somewhat delayed in 
rescued embryos, cardiomyocytes complete cardiac fusion and initiate heart 
tube extension by 26 hours post fertilization (hpf).  Interestingly, tmem2 
overexpression also impacts the endocardium.  Similar to its rescue of 
myocardial fusion, myocardial expression of tmem2 is sufficient to rescue 
endocardial fusion and tube formation in MZtmem2 mutants (Fig. 1.4E-F) 
(Totong et al., 2011). These data suggest that Tmem2 influences the 
extracellular environment through which both myocardial and endocardial cells 
move as they undergo cardiac fusion.  In Chapter 2, we interrogate this model 
of Tmem2 function by examining deposition of ECM components surrounding 
MZtmem2 mutant cardiomyocytyes.  In Chapter 3, we evaluate which regions 
of the Tmem2 protein are critical for promotion of cardiomyocyte movement.  
 
Skeletal muscle morphogenesis requires cell-matrix interactions 
Skeletal muscle morphogenesis involves multiple developmental 
processes that all require adhesion to the ECM (Goody et al., 2015).  In 
vertebrates, muscle precursors originate within somites, the repeating 
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segments of paraxial mesoderm that flank the embryonic notochord and 
comprise the embryonic myotome (Bryson-Richardson and Currie, 2008; 
Buckingham and Vincent, 2009).  These muscle cells elongate across each 
somite segment and attach to ECM at the somite boundaries (Gros et al., 
2004; Snow et al., 2008a).  Cell-ECM adhesions link muscles to tendons at the 
myotendinous junction (MTJ) (Fig. 1.5A,B) (Gillies and Lieber, 2011), which is, 
in turn, needed to transmit force to the skeletal system (Charvet et al., 2012).  
Not surprisingly, disruption of muscle adhesion to the basement membrane 
(BM) can lead to congenital muscular dystrophies (Bertini et al., 2011; 
Kirschner, 2013).  Clearly, adhesion of muscle cells to the BM is critical for the 
normal progression of muscle morphogenesis and for muscle function.  The 
adhesion of muscle fibers relies on two principal components: cell-matrix 
adhesion complexes (CMACs) and ECM composition.       
Several transmembrane receptors concentrate at somite boundaries as 
part of cell-matrix adhesion complexes (CMACs) (Fig. 1.5A,B) (Bajanca et al., 
2006; Julich et al., 2005; Lunardi and Dente, 2002; Moreau et al., 2003; 
Parsons et al., 2002a; Schofield et al., 1995; Song et al., 1992).  Two major 
protein complexes involved in cell-matrix attachments are integrin 
heterodimers and the dystrophin-associated glycoprotein complex (DGC).  
Integrin adhesion complexes organize at somite boundaries and bind the ECM 
protein fibronectin, coordinating fibronectin polymerization (Julich et al., 2009; 
Lackner et al., 2013).  Dystroglycan is a main component of the DGC and is 
	  	  
8 
initially expressed as a single precursor protein, encoded by dag1, which is 
then cleaved into α and β subunits (Holt et al., 2000; Ibraghimov-Beskrovnaya 
et al., 1992).  β-dystroglycan (βDG) is the transmembrane subunit and links 
the DGC to the cytoskeleton, whereas α-dystroglycan (αDG) binds to laminin, 
a major component of the BM (Ervasti and Campbell, 1993; Yamada et al., 
1994).   
In zebrafish, dag1 morphants and mutants exhibit disorganized and 
apoptotic muscle cells as well as destabilization of myofiber attachments to 
somite boundaries (Gupta et al., 2012; Parsons et al., 2002a).  Further, 
glycosylation of αDG is critical for it to bind ligands within the BM (Gee et al., 
1994; Inamori et al., 2012; Moore and Winder, 2012; Sciandra et al., 2013).  
Mutations in genes required for glycosylation of αDG result in muscle diseases 
referred to as dystroglycanopathies (Godfrey et al., 2011; Kawahara et al., 
2009). Thus, not only do CMACs have to be present at somite boundaries, but 
they also have to be appropriately modified in order to enable muscle fiber 
adhesion to the BM.  
In addition to CMACs, the connection between muscle fibers and 
somite boundaries during skeletal muscle morphogenesis also relies upon 
appropriate deposition of the ECM components fibronectin and laminin (Fig. 
1.5C).  For example, zebrafish fibronectin morphants have aberrant fast-twitch 
muscle patterning and exhibit disorganized muscle fibers (Snow et al., 2008b).  
Meanwhile, failed polymerization of laminin at the MTJ results in excessively 
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long muscle fibers crossing over somite boundaries (Goody et al., 2010), and 
zebrafish candyfloss mutants, deficient in laminin α2, exhibit retraction of 
fibers from the MTJ following muscle contraction (Hall et al., 2007).  Clearly, 
adhesion complexes and matrix proteins are critical players in the 
maintenance of muscle fiber integrity and function.  Taken together, these 
studies reveal a fascinating dynamic between the ECM and CMACs during 
myoskeletal morphogenesis and homeostasis.   
While cell-matrix attachments are clearly essential for muscle 
development, the way in which these interactions are regulated is less well 
defined.  Intriguingly, our initial observations of MZtmem2 mutants revealed 
defects in somite morphology (Totong et al., 2011).  Namely, MZtmem2 
mutants exhibit slightly curved somites that are U-shaped rather than chevron-
shaped.  Closer investigation of this phenotype uncovered underlying issues 
with muscle fiber attachments.  In Chapter 2 of this thesis, we demonstrate 
that Tmem2 influences both matrix organization and cell adhesion complexes 
at the MTJ and discuss the role of Tmem2 in regulating cell-matrix interactions 
that are essential for muscle fiber stabilization during morphogenesis. 
 
The atrioventricular canal: a distinct subunit of the heart 
The primitive heart begins as a linear tube comprised of two layers: an 
inner, vascular layer, the endocardium, and an outer layer of muscle, the 
myocardium.  Between these two layers is a lining of ECM known as the 
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cardiac jelly.  During development, signaling between the endocardium and 
myocardium at the boundary between the ventricle and the atrium triggers the 
formation of endocardial cushions (Fig. 1.7) (Eisenberg and Markwald, 1995).  
These cushions are eventually remodeled into valve flaps that prevent 
retrograde blood flow (Hu et al., 2000).  The tightly defined region of the heart 
in which endocardial cushions develop is called the atrioventricular canal 
(AVC).   
Cells within the AVC must differentiate and undergo specific structural 
changes for correct endocardial cushion formation to occur (Fig. 1.7).  For 
example, endocardial AVC cells change shape from squamous to cuboidal 
(Beis et al., 2005) and specifically express notch1b and has2 (Hurlstone et al., 
2003) as well as cell adhesion molecule Dm-grasp/Alcam (Beis et al., 2005).  
A subset of endocardial cells transdifferentiate from epithelial to mesenchymal 
cells, a process called epithelial to mesenchymal transition (EMT).  After EMT, 
they invade the cardiac jelly where they proliferate and contribute to the 
swelling of the EC (Markwald et al., 1977).  These AVC-specific changes in 
cell shape and gene expression are accompanied by an increase in the AVC 
cardiac jelly (Moorman and Christoffels, 2003). In contrast, cells directly 
adjacent to the AVC do not undergo these changes and maintain their identity 
as ventricular or atrial cells.   
Although the mechanism for coordination of atrioventricular 
differentiation is unclear, we do understand that signaling between the 
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endocardium and the myocardium is crucial for endocardial cushion 
development.  Ex vivo cushion explant systems have shown the necessity for 
myocardial signaling in epithelial to mesenchymal transdifferentiation (EMT) of 
endocardial cells.  In these experiments, myocardial explants were shown to 
promote seeding of endocardial cushion tissue cells into a three-dimensional 
collagen lattice (Runyan and Markwald, 1983).  Further, these experiments 
elucidated the regional specificity of cell signaling control, showing that 
endocardium from the cushion-forming region is solely capable of responding 
to myocardial differentiation signals. 
 Evidence suggests that at least one of the relevant AVC differentiation 
signals being communicated between the endocardium and the myocardium is 
Wnt.  During canonical Wnt signaling (Fig. 1.8), Wnt ligand binds to a frizzled 
(FZ) family transmembrane receptor (Mao et al., 2001a; Mao et al., 2001b; 
Tamai et al., 2000) and the ensuing signal prevents β-catenin from being 
tagged for degradation by the axin-containing destruction complex (Fig. 1.8A) 
(Nelson and Nusse, 2004).  β-catenin then translocates to the nucleus where it 
activates downstream transcription factors (Fig. 1.8B) (Fodde et al., 2001).  
The adenomatous polyposis coli (Apc) protein is part of the axin-containing 
destruction complex and its loss of function results in constitutively active Wnt 
signaling.  Zebrafish apc mutants with increased Wnt signaling exhibit several 
AVC defects including hyperplastic endocardial cushions and expansion of 
AVC molecular markers such as bmp4 (Hurlstone et al., 2003).  Conversely, 
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inhibition of Wnt signaling through over-expression of Axin1 led to reduced 
bmp4 expression in the AVC (Verhoeven et al., 2011), thus revealing that 
bmp4 is regulated downstream of canonical Wnt signaling.   
This same work also placed tbx2 as a downstream mediator of bmp4 in 
the pathway patterning AVC differentiation (Verhoeven et al., 2011).  Tbx2 null 
mutant mice exhibit abnormally small endocardial cushions as well as aberrant 
expression of chamber markers within what is typically the AVC (Habets et al., 
2002; Harrelson et al., 2004).  On the other hand, over-expression of tbx2 
resulted in expansion of ECs (Shirai et al., 2009).  Additional studies in mice 
highlighted the role of Tbx2 as a transactivator of Hyaluranon synthase 2 
(Has2), which encodes the major enzyme responsible for the synthesis of 
hyaluronic acid (HA) (Shirai et al., 2009).  The glycosaminoglycan HA is a 
major constituent of the cardiac jelly (Schroeder et al., 2003).  Over-expression 
of Tbx2 induces ectopic HA deposition in the cardiac jelly of both ventricular 
and atrial chambers (Shirai et al., 2009).  Taken together, it is clear that the 
Wnt signaling pathway, along with its downstream effectors, are crucial to the 
proper differentiation of the AVC.  How Wnt signaling is itself regulated, 
however, is less clear.  Importantly, the ECM could be a potential regulator of 
the Wnt signaling pathway.   
Between the endocardium and the myocardium is a dynamic layer of 
ECM consisting of proteoglycans and glycosaminoglycans (Valiente-Alandi et 
al., 2016).  Correspondingly, mutations affecting synthesis of several ECM 
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components cause defective AVC formation.  For example, the zebrafish 
mutant jekyll fails to form endocardial cushions and exhibits no constriction of 
the AVC region.  This phenotype is caused by disruption of the gene that 
encodes UDP-glucose dehydrogenase, one of the enzymes responsible for 
HA synthesis (Walsh and Stainier, 2001).   
Another enzyme required for HA synthesis is hyaluronan synthase, 
encoded by the gene has2.  Has2 mutant mice display a complete absence of 
cardiac jelly (Camenisch et al., 2000).  Without cardiac jelly, endocardial cells 
of the AVC region fail to transdifferentiate and endocardial cushions are not 
formed.  Adding back HA, however, rescues endocardial cushion formation in 
the Has2 knockout mice.  Conversely, zebrafish dicer mutants display both 
excessive HA deposition and ectopic endocardial cushion differentiation 
(Lagendijk et al., 2011).  Knockdown of has2 is able to rescue this phenotype 
and results in proper AVC restriction.   
Like HA, CS has been shown to be critical for the appropriate 
development of the AVC.  In zebrafish embryos, chemical inhibition of CS 
synthesis results in loss of AVC constriction, causing a phenotype much like 
the jekyll mutant (Peal et al., 2009).  Taken together, these studies reveal that 
ECM composition is critical for appropriate AVC development.  However, the 
means by which ECM deposition is spatially regulated remains poorly 
understood.  Mutations in the zebrafish gene tmem2 provide a valuable entry 
point for addressing these open questions.   
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Tmem2 restricts atrioventricular canal differentiation 
In wild-type embryos, expression of the endocardial AVC marker, 
notch1b, and myocardial AVC markers, bmp4 and versican, is restricted to the 
AVC region by 48 hpf.  In contrast, tmem2 mutants fail to restrict these AVC 
markers by 48 hpf (Fig. 1.9A-F).  These mutants also fail to restrict 
endocardial localization of the AVC molecular marker, Dm-grasp, (Totong et 
al., 2011).  In tmem2 mutants, DM-grasp staining is expanded throughout the 
ventricular endocardium as well as the AVC (Fig. 1.9G-L) (Totong et al., 2011).  
Taken together, these data show that tmem2 mutants exhibit ectopic 
atrioventricular differentiation.   
Interestingly, in addition to AVC restriction defects, tmem2 mutants also 
exhibit aberrant hyaluronic acid deposition.  Whereas wild-type embryos have 
localized accumulation of hyaluronic acid at the AVC, tmem2 mutant hearts 
display grossly expanded HA deposition throughout the ventricle (Smith et al., 
2011).  Overall, these data suggest that Tmem2 could function to restrict 
atrioventricular differentiation through regulation of HA deposition.  In Chapter 
3, we present our findings supporting a model for Tmem2 function through HA 
regulation.  
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Tmem2 structure and function 
Clearly, Tmem2 plays multiple roles in cardiac and skeletal muscle 
morphogenesis: Tmem2 functions to promote cardiac fusion, stabilize muscle 
fiber attachments, and restrict AVC differentiation.   Further, these functions of 
Tmem2 most likely involve the regulation of ECM.  What is less clear, 
however, is the precise mechanism by which Tmem2 executes its functions.  
The structure of the Tmem2 protein leaves open many options for its 
biochemical role.  The goal of my thesis research has been to determine the 
mechanism through which Tmem2 accomplishes its various tasks.  At the time 
that the studies presented in Chapters 2 and 3 were initiated, very little was 
known about the molecular mechanism of Tmem2 function.  In this section, I 
will outline what was known about Tmem2 structure in the preliminary stages 
of our research, as well as review findings from recent studies that have 
provided new insight into Tmem2 activity.  
Tmem2 is a predicted single-pass type II transmembrane protein with a 
short cytoplasmic portion and an extended extracellular region (Fig. 1.12) 
(Smith et al., 2011; Totong et al., 2011).  Within the Tmem2 extracellular 
region, there are four recognized domains – the G8 domain, several PbH1 
repeats, and two Pander-like domains.  PbH1 repeats typically form pectin 
lyase folds with enzymatic activity capable of degrading polysaccharides 
(Henrissat et al., 1995; Mayans et al., 1997).  Although their precise function 
remains unclear, Pander-like domains have been shown to be present in 
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proteins involved in apoptosis and metastasis and glycosylation (Cao et al., 
2003; Johansson et al., 2013; Pereira et al., 2014; Yoshida et al., 2013).  The 
G8 domain of the human PKHD1 protein has been associated with polycystic 
kidney disease (He et al., 2006) and mutations within the G8 region of the 
KIAA1199 protein are associated with non-syndromic hearing loss (Abe et al., 
2003).  
Although there are several identified domains within Tmem2, they are 
poorly characterized and do not immediately suggest a biochemical role for 
Tmem2 during cardiac and muscle morphogenesis.  Despite this, the structure 
of Tmem2 does closely resemble that of the KIAA1199 protein, also known as 
cell migration-inducing and hyaluranon binding protein (CEMIP).  KIAA1199 is 
a soluble rather than transmembrane protein; however, it contains a G8, PLT, 
and PL domain as well as three conserved PbH1 repeats (Yoshida et al., 
2013).  KIAA1199 has been shown to bind the EGF receptor and activate EGF 
signaling in cervical cancer cells (Shostak et al., 2014).  Additionally, 
KIAA1199 promotes cell migration in cultured fibroblast cells (Evensen et al., 
2013).  Most interestingly, KIAA1199 has been identified as a hyaluronidase in 
synovial fibroblasts whose activity relies on the clathrin-coated pit pathway 
(Yoshida et al., 2013).  Research illustrating the ability of KIAA1199 to bind 
and depolymerize HA yielded key support toward the hypothesis that Tmem2 
could function through regulation of HA.   
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 Building upon this, recent work in mammalian cell culture has 
demonstrated that Tmem2 can function as a cell-surface hyaluronidase.  HEK 
293T cells transiently transfected with FLAG-tagged full-length TMEM2 cDNA 
gained the ability to depolymerize HA molecules within the range of 20-1500 
kDa, into fragments of ~5 kDa (Yamamoto et al., 2017).  In Tmem2, amino 
acid residue 265 positionally corresponds to site of the deafness mutation 
(residue 187) in human KIAA1199 (Abe et al., 2003; Yoshida et al., 2013).  A 
similar point mutation of residue 265 in Tmem2 abolished its ability to degrade 
HA (Yamamoto et al., 2017), confirming that this region within the PLT domain 
is critical for Tmem2 activity in HA catabolism.   
Importantly, the ability of Tmem2 to depolymerize HA was recently 
shown to be essential for the role of Tmem2 in promoting angiogenesis.  
Zebrafish tmem2 mutants exhibit intersegmental vessel (ISV) sprouting 
defects as well as excess HA deposition surrounding stunted ISVs (De Angelis 
et al., 2017).  Degradation of HA with hyaluronidase treatment rescued ISV 
sprouting in tmem2 mutants.  These findings support a model wherein Tmem2 
promotes angiogenesis through regulating local HA levels.  Interestingly, 
overexpression of partially degraded HA was also able to efficiently rescue 
ISV sprouting in mutants, suggesting that Tmem2 regulates these processes 
through HA depolymerization specifically (De Angelis et al., 2017).  Does 
Tmem2 act in a similar way in order to restrict AVC differentiation?  In Chapter 
3, I will examine the link between Tmem2, HA regulation, and AVC patterning.      
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Summary 
Prior studies provide substantial evidence that regulation of the ECM is 
frequently a crucial component of cardiac and skeletal muscle morphogenesis.  
However, we have an incomplete understanding of the way in which ECM 
organization is controlled and how ECM organization, in turn, informs 
morphogenetic programs.  We speculate that the transmembrane protein 
Tmem2 coordinates ECM organization in multiple embryonic tissues.  In 
Chapter 2, I will present studies that demonstrate the role of Tmem2 in 
regulating cell-matrix interactions that are essential for muscle fiber 
attachment.  In Chapter 3, I will examine how Tmem2 structure influences its 
function within multiple developmental contexts as well as link Tmem2 
regulation of HA to the process of AVC differentiation.  Finally, in Chapter 4, I 
will integrate these ideas and present future directions toward elucidating the 
mechanisms through which ECM influences	  embryonic development.  
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Figure 1.1. Schematic view of heart development in zebrafish 
Dorsal (A-C) and frontal (D) views of zebrafish cardiac development.  (A) Atrial 
(yellow) and ventricular (red) myocardial progenitors cluster into bilateral groups. (B) 
Cardiomyocytes then migrate toward the embryonic midline and fuse, forming a ring 
(Berdougo et al., 2003; Yelon et al., 1999).  (C) This ring then elongates into to the 
primitive heart tube.  (D) By 48 hours post fertilization (hpf), the heart has undergone 
looping, and restriction at the atrioventricular canal (AVC) separates the ventricular 
and atrial chambers.  Adapted from (Schoenebeck and Yelon, 2007).  
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Figure 1.2. Both loss of fibronectin (FN) and excessive FN can hinder 
cardiomyocyte movement 
(A,B) Transverse sections of the right side of the lateral plate mesoderm at 20 
somites (som), dorsal up.  Adapted from (Trinh et al. 2005).  (A) In wild-type (wt) 
cardiomyocytes (pseudocolored blue), Fn (green) is deposited basally. (B) In hand2 
(han) mutants, Fn is widely and irregularly distributed. (C-G) Expression of myl7 at 22 
som; dorsal views, anterior up, Adapted from (Garavito-Aguilar et al., 2010).  (C, D) At 
this stage, a ring of cardiomyocytes has formed in wt embryos (C), but han mutants 
(D) never exhibit cardiac fusion (Yelon et al., 2000).  (E) The nat mutation in the 
zebrafish fn1 gene causes cardia bifida (Trinh and Stainier, 2004).  (F) Heterozygosity 
for nat in han mutants rescues cardiac fusion, indicating that excess Fn is responsible 
for hindering cardiomyocyte movement in han mutants. 
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Figure 1.3. MZtmem2 mutants exhibit defects in both myocardial and 
endocardial medial movement 
(A,B) Expression of myl7 at 20 somites (som) and (C,D) Tg(vegfr2:g-rcfp) at 24 hpf; 
dorsal views, anterior up.  Arrows indicate endocardium.  Note that frv is the original 
allele designation for this specific mutation in tmem2.  Myocardial and endocardial 
medial movement are normal in Mtmem2 (A,C) and zygotic tmem2 mutants and are 
hindered in MZtmem2 (B,D) mutants. (E,F) Immunofluorescence employing the MF20 
and S46 antibodies demonstrates that Mtmem2 (E) mutant embryos develop normally 
looped hearts with a distinct ventricle (red) and atrium (green).  (F) In MZtmem2 
mutant embryos, the heart remains bifurcated with subdivided ventricular (red) and 
atrial (green) chambers.  Adapted from (Totong et al., 2011). 
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Figure 1.4. MZtmem2 mutant myocardial and endocardial fusion defects are 
rescued by myocardial tmem2 expression 
(A-D) Expression of myl7 at 26 hpf and (E-H) the endothelial cadherin gene cdh5 
(Larson et al., 2004) at 32 hpf; dorsal views, anterior up.  Arrows in E-H indicate the 
endocardium.  Note that frv is the original allele designation for this specific mutation 
in tmem2.  The transgene Tg(cmlc2:tmem2-gfp) (C,D,G,H) drives expression of a 
Tmem2-Gfp fusion protein in the myocardium.  Whereas transgene expression has 
no effect on Mtmem2 embryos (A,C,E,G), it rescues both myocardial movement (B,D) 
and endocardial movement (F, H) in MZtmem2 embryos.  Adapted from (Totong et 
al., 2011). 
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Figure 1.5. Extracellular matrix is crucial for attachment of muscle cells to the 
myotendinous junction  
(A) Cartoon schematizes adhesive interactions between muscle cells and the 
extracellular matrix (ECM).  Cell-matrix adhesion complexes (CMACs) link the ECM to 
the actin cytoskeleton within muscle cells.  (B) ECM surrounds individual muscle 
fibers and is also organized at the myotendinous junction (MTJ). (C) Fluorescence 
depicts phalloidin (red) and laminin-111 (green) in a 24 hpf zebrafish embryo.  Side 
view, anterior left, dorsal top. Muscle cells elongate and attach to laminin-rich somite 
boundaries that develop into MTJs.  Reproduced from (Goody et al., 2015).  
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Figure 1.6. Schematic of the morphological changes in the zebrafish 
atrioventricular canal (AVC) between 24 and 96 hpf 
Ventricle, red.  Atrium, green.  At 24 hpf, the primitive heart tube consists of an outer 
myocardial layer and an inner endocardial layer separated by a thin layer of 
extracellular matrix (ECM).  Between 30-48 hpf, endocardial cells within the AVC 
(white) undergo structural changes and become cuboidal in shape.  In addition, 
cardiac jelly deposition (sky blue) becomes enriched within endocardial cushions by 
48 hpf.  Reproduced from (Peal et al., 2009).  
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Figure 1.7. Schematic of the canonical Wnt signaling pathway 
(A) In the absence of Wnt ligands, β-catenin associates with the axin destruction 
complex, which includes the tumor suppressor Adenomatous polyposis coli (APC).  
This association targets β-catenin for phosphorylation and subsequent ubiquitylation, 
ultimately leading to the degradation of β-catenin by the proteasome. (B) When Wnt 
ligands are available, they bind to the Frizzled transmembrane receptor and its co-
receptors. Wnt ligand-receptor engagement prevents ubiquitylation of β-catenin and 
results in the translocation of β-catenin to the nucleus, where it binds to TCF 
transcription factors and activates downstream target genes.  Reproduced from (Staal 
and Clevers, 2005).   
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Figure 1.8 tmem2 mutants display ectopic localization of atrioventricular canal 
(AVC) markers.  
(A-F) Frontal views showing expression of atrioventricular canal (AVC) markers in 
wild-type (wt) (A-C) and tmem2 mutant embryos (D-F) at 48 hpf.  Dotted lines outline 
the heart chambers. In wild-type embryos, expression of molecular markers such as 
notch1b (A), bpm4 (B), and versican (C) are restricted to the AVC region.  In contrast, 
tmem2 mutants fail to restrict expression of these markers to the AVC (D-F).  (G-L) 
Three-dimensional projections of confocal sections of wild-type (G-I) and tmem2 
mutant (J-L) hearts expressing Tg(kdrl:GRCFP) (green) in the endocardium at 57 hpf.  
Immunofluorescence depicts Dm-grasp (red) throughout the myocardium and in the 
endocardium of the AVC (arrowheads).  In tmem2 mutants, Dm-grasp is ectopically 
localized in the ventricular endocardium. A, atrium; V, ventricle.  Adapted from 
(Totong et al., 2011).  
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Figure 1.9. Predicted structure of the Tmem2 protein   
The Tmem2 protein is predicted to encode a type II transmembrane protein, 
containing a single transmembrane domain (TM) and a small cytoplasmic region (C).  
In its extracellular portion, Tmem2 contains a G8 domain, a Pander-like Tmem2 
domain (PLT), three parallel beta helix repeats (PbH1), and a Pander-like domain 
(PL).   
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Chapter 2: Tmem2 regulates cell-matrix interactions that are essential 
for muscle fiber attachment 
 
 
Reprinted from: 
Lucile Ryckebusch, Lydia Hernandez, Carole Wang, Jenny Phan, Deborah 
Yelon, “Tmem2 regulates cell-matrix interactions that are essential for muscle 
fiber attachment.” Development, 2016. 143(16): p.2965-2972. 
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Summary Statement 
The transmembrane protein Tmem2 facilitates muscle fiber attachment 
by influencing both the organization of the extracellular matrix and the 
glycosylation of α-dystroglycan.  
 
Abstract 
Skeletal muscle morphogenesis depends upon interactions between 
developing muscle fibers and the extracellular matrix (ECM) that anchors 
fibers to the myotendinous junction (MTJ).  The pathways that organize the 
ECM and regulate its engagement by cell-matrix adhesion complexes 
(CMACs) are therefore essential for muscle integrity.  Here, we demonstrate 
the impact of transmembrane protein 2 (tmem2) on cell-matrix interactions 
during muscle morphogenesis in zebrafish.  Maternal-zygotic tmem2 
(MZtmem2) mutants exhibit muscle fiber detachment, in association with 
impaired laminin organization and ineffective fibronectin degradation at the 
MTJ.  Similarly, disorganized laminin and fibronectin surround MZtmem2 
cardiomyocytes, which could account for their hindered movement during 
cardiac morphogenesis.  In addition to ECM defects, MZtmem2 mutants 
display hypoglycosylation of α-dystroglycan within the CMAC, which could 
contribute to the observed fiber detachment.  Expression of the Tmem2 
ectodomain can rescue aspects of the MZtmem2 phenotype, consistent with a 
possible extracellular function of Tmem2.  Together, our results suggest that 
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Tmem2 regulates cell-matrix interactions by affecting both ECM organization 
and CMAC activity.  These findings evoke possible connections between the 
functions of Tmem2 and the etiologies of congenital muscular dystrophies, 
particularly dystroglycanopathies.  
 
INTRODUCTION  
In vertebrates, most skeletal muscles derive from precursors found 
within the somites, repetitive segments of paraxial mesoderm that flank the 
embryonic notochord (Bryson-Richardson and Currie, 2008; Buckingham and 
Vincent, 2009).  As muscle precursors mature, they elongate to form fibers 
that span each segment and attach to the somite boundaries (Goody et al., 
2015).  Attachments are created through direct interactions of muscle fibers 
with the extracellular matrix (ECM), and sites of attachment develop into the 
myotendinous junction (MTJ), which transmits muscular forces to the skeletal 
system (Charvet et al., 2012).  Thus, cell-matrix connections facilitate the 
morphology, integrity, and function of developing muscles.  In contrast, failure 
to maintain fiber attachments can lead to the progressive tissue degeneration 
that underlies muscular dystrophy.  Although numerous causative mutations 
have been associated with congenital muscular dystrophies (Bertini et al., 
2011; Kirschner, 2013), our understanding of the molecular mechanisms that 
regulate muscle fiber attachment remains incomplete.   
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Several protein complexes are known to play primary roles in 
connecting muscle cells to the MTJ (Charvet et al., 2012; Goody et al., 2015; 
Thorsteinsdottir et al., 2011).  Within the ECM, deposition of both fibrillar 
fibronectin and polymerized laminin is crucial for successful anchoring of 
muscle fibers.  These ECM molecules are engaged by a variety of 
transmembrane receptors at fiber termini, including integrin heterodimers and 
the dystrophin-associated glycoprotein complex (DGC).  In collaboration with 
cytoplasmic proteins like focal adhesion kinase (FAK) and paxillin, these 
receptors form cell-matrix adhesion complexes (CMACs) that link the 
extracellular environment to the cytoskeleton and thereby facilitate both force 
transmission and signaling.  Whereas the importance of ECM and CMAC 
components is well documented, it is less clear how deposition of the ECM is 
controlled or how CMAC assembly is regulated in order to insure appropriate 
cell-matrix interactions.   
The use of the zebrafish as a model organism provides valuable 
opportunities for interrogating the functions of genes involved in muscle fiber 
attachment (Berger and Currie, 2012; Gibbs et al., 2013).  Here, we show that 
the zebrafish gene transmembrane protein 2 (tmem2) plays an important and 
previously unappreciated role in regulating cell-matrix interactions at the MTJ.  
Tmem2 is a type II transmembrane protein with a small cytoplasmic domain, a 
single-pass transmembrane domain, and a large ectodomain (Smith et al., 
2011; Totong et al., 2011).  Prior studies have demonstrated that tmem2 
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regulates the regional restriction of the cardiac atrioventricular canal (Smith et 
al., 2011; Totong et al., 2011).  In addition, embryos lacking both maternal and 
zygotic supplies of tmem2 (MZtmem2) exhibit earlier defects in multiple 
tissues, including aberrantly shaped somites (Totong et al., 2011).  Through 
analysis of the somite defects in MZtmem2 mutants, we find that loss of 
tmem2 function leads to muscle fiber detachment.  Our results indicate that 
tmem2 is required for appropriate ECM deposition during skeletal muscle 
morphogenesis, as well as for deposition of the ECM that surrounds 
cardiomyocytes during heart tube formation.  In addition, tmem2 promotes the 
glycosylation of α-dystroglycan within the DGC at the MTJ.  Thus, our studies 
suggest that Tmem2 impacts cell-matrix interactions by influencing both ECM 
organization and CMAC post-translational modification.      
 
RESULTS AND DISCUSSION 
Loss of tmem2 function leads to muscle fiber detachment  
Our prior studies indicated that embryos lacking both maternal and 
zygotic supplies of tmem2 (MZtmem2) exhibit abnormal somite morphology, 
whereas embryos lacking only maternal supplies of tmem2 (Mtmem2) are 
indistinguishable from wild-type (Fig. 2.1A,D) (Totong et al., 2011).  Notably, 
instead of the chevron-shaped somites seen in Mtmem2 embryos, MZtmem2 
mutants display U-shaped somites (Fig. 2.1B,E).  Formation of chevron-
shaped somites requires Hedgehog signaling from the notochord (Barresi et 
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al., 2000; Blagden et al., 1997; Henry and Amacher, 2004); however, the 
morphology, integrity, and differentiation of the MZtmem2 notochord appear 
relatively normal (Figs. 2.1C,F, 2.S1B,D).  Moreover, the MZtmem2 somite 
shape does not seem to result from defective Hedgehog signaling, since ptc1 
expression appears intact in MZtmem2 mutants (Fig. 2.S1A,C).   
We investigated whether defects in muscle fiber morphogenesis could 
underlie the aberrant somite shape in MZtmem2 mutants.  MZtmem2 embryos 
exhibit a normal number of somites (Fig. 2.1A,D) and have no apparent 
defects in initial somite boundary formation (Fig. 2.S2A,B).  However, muscle 
fiber attachment defects are prevalent in MZtmem2 mutants (Fig. 2.1G,H).  
Both fast and slow fibers exhibit detachment from the MTJ (Figs. 2.1H, 2.S3); 
in addition, some muscle fibers aberrantly cross the MTJ (Fig. 2.1H).  Fiber 
detachment becomes more widespread as development proceeds (Figs. 
2.1J,K, 2.S4A,B), indicating failure to properly maintain attachments.  
Consistent with this, although zygotic tmem2 (Ztmem2) mutants exhibit normal 
somite morphology at early stages, defects in somite shape and muscle fiber 
integrity emerge in some Ztmem2 mutants over time (Fig. 2.S4C-G), 
presumably as maternal supplies of tmem2 are depleted.  Together, these 
results provide the first demonstration that tmem2 plays an important role in 
preserving muscle fiber attachment to the MTJ.   
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Tmem2 regulates organization of basement membrane components  
Establishment and maintenance of muscle fiber attachment at the MTJ 
require successful interactions with the ECM molecules that compose the 
basement membrane (Goody et al., 2015; Snow and Henry, 2009).  Moreover, 
the MZtmem2 phenotype shares some characteristics with the phenotypes of 
laminin-deficient and fibronectin-deficient embryos, including the presence of 
fibers that cross the MTJ (Snow et al., 2008a; Snow et al., 2008b), prompting 
us to investigate the ECM in MZtmem2 mutants.  Instead of the normally 
concentrated deposition of laminin at the MTJ in Mtmem2 embryos (Fig. 
2.2A,C), we observed diminished and poorly organized laminin in MZtmem2 
mutants (Fig. 2.2B,D), particularly in locations where fibers were detached 
(Fig. 2.2D).  In contrast, fibronectin deposition appears relatively robust, albeit 
somewhat disorganized, in MZtmem2 mutants (Figs. 2.S2A-F, 2.2E,F).  During 
the usual progression of muscle morphogenesis (Jenkins et al., 2016; Snow 
and Henry, 2009), fibronectin levels degrade at the MTJ over time (Fig. 
2.2E,G), in conjunction with accumulation of laminin (Fig. 2.2A,C).  However, 
in MZtmem2 mutants, fiber attachment defects are accompanied by aberrantly 
increased fibronectin localization (Fig. 2.2F,H).  This may represent a 
secondary consequence of laminin deficiency, since organized laminin has 
been shown to play an indirect role in facilitating fibronectin degradation at the 
MTJ (Jenkins et al., 2016); alternatively, increased fibronectin could be a 
secondary response to muscle fiber detachment, akin to the increased 
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fibronectin fibrillogenesis seen in association with some myopathies (Hori et 
al., 2011; Rampoldi et al., 1986; Zacharias et al., 2011).   
The deficient and disorganized ECM at the MZtmem2 MTJ made us 
wonder whether ECM defects could account for other aspects of the MZtmem2 
mutant phenotype.  MZtmem2 mutants exhibit cardia bifida, reflecting an early 
failure of cardiac morphogenesis (Totong et al., 2011).  In wild-type embryos, 
bilateral populations of cardiomyocytes move toward the midline, where they 
meet and merge to assemble the heart tube through a process called cardiac 
fusion.  MZtmem2 mutants fail to execute cardiac fusion and instead display 
two separated groups of cardiomyocytes in bilateral positions (Fig. 2.3F,G) 
(Totong et al., 2011).  The composition of the basement membrane has a 
potent influence on cardiac fusion: either diminished or excessive ECM 
deposition can inhibit cardiomyocyte movement (Arrington and Yost, 2009; 
Garavito-Aguilar et al., 2010; Trinh and Stainier, 2004).  Interestingly, the ECM 
adjacent to the MZtmem2 myocardium exhibits irregular and disorganized 
deposition of both laminin and fibronectin (Fig. 2.3A-E), which could account 
for the failure of cardiac fusion in MZtmem2 mutants.  Thus, our data suggest 
that Tmem2 regulates both cardiac and skeletal muscle morphogenesis via 
modulation of the ECM.    
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The Tmem2 ectodomain can enact aspects of Tmem2 function 
Since the biochemical function of Tmem2 is currently unknown, it 
remains unclear whether this protein could exert its influence on the basement 
membrane through direct interaction with ECM components.  To evaluate 
whether the Tmem2 ectodomain is sufficient to execute its functions, we 
replaced the transmembrane and cytoplasmic domains of Tmem2 with a 
signal peptide and tested whether this modified version of Tmem2 can rescue 
the MZtmem2 mutant phenotype.  Injection of wild-type tmem2 mRNA into 
MZtmem2 mutants can rescue both muscle fiber attachment (Fig. 2.1I,L; Table 
2.S1) and cardiac fusion (Fig. 2.3F-K; Table 2.S2).  Similarly, we found that 
the Tmem2 ectodomain can also ameliorate both of these features of the 
MZtmem2 phenotype, although less efficiently than full-length Tmem2 (Fig. 
2.1L; Tables 2.S1, 2.S2).  Therefore, the Tmem2 ectodomain can mediate at 
least some of the molecular functions of Tmem2, consistent with a model in 
which Tmem2 functions within the extracellular environment.   
 
Tmem2 influences glycosylation of alpha-dystroglycan  
Our results suggest that the muscle fiber detachments in MZtmem2 
mutants could be a direct consequence of faulty ECM organization.  Since 
fiber attachment also relies upon effective CMAC assembly (Goody et al., 
2010; Goody et al., 2015; Jackson and Ingham, 2013), we investigated 
whether the MTJ defects in MZtmem2 mutants are restricted to the basement 
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membrane or are also reflected in the localization of CMAC components.  
Examination of three components of the DGC – the scaffolding protein paxillin, 
a phosphorylated form of FAK (pFAK), and the core complex component β-
dystroglycan (βDG) – demonstrated that each was localized to the MTJ in 
MZtmem2 mutants (Fig. 2.4A-F).  However, the distribution of each 
component was affected: paxillin was not properly concentrated (Fig. 2.4A,B), 
pFAK levels appeared reduced (Fig. 2.4C,D), and some gaps in bDG 
localization were observed (Fig. 2.4E,F).  These aberrations could reflect 
ineffective CMAC assembly due to poor ECM engagement, or they could 
represent CMAC displacements that are secondary to fiber detachment 
(Bassett et al., 2003; Jacoby et al., 2009).  Together, these observations 
suggest that recruitment of CMAC components to the MTJ does not require 
Tmem2, but that Tmem2 influences CMAC organization and integrity.   
Our analysis of dystroglycan localization at the MZtmem2 MTJ also 
revealed a significant defect in the glycosylation of α-dystroglycan (αDG) (Fig. 
2.4E,F).  Dystroglycan is post-translationally cleaved into two subunits, αDG 
and βDG (Moore and Winder, 2012).  αDG functions as a laminin receptor, 
and its affinity for laminin depends upon its proper glycosylation (Sciandra et 
al., 2013).  Strikingly, the glycosylated form of αDG is barely detectable at the 
MZtmem2 MTJ, even though βDG localization is robust (Figs. 2.4F,H, 2.S5C; 
Table 2.S3).  The influence of Tmem2 on αDG glycosylation may require its 
transmembrane and/or cytoplasmic domains: whereas full-length Tmem2 can 
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rescue glycosylation in MZtmem2 mutants, the Tmem2 ectodomain cannot 
(Figs. 2.4G,H, 2.S5C; Table 2.S3).  Thus, in addition to its effects on ECM 
organization, Tmem2 promotes αDG glycosylation and, presumably, DGC 
activity, and this function of Tmem2 may employ a mechanism distinct from its 
other roles.   
 
Tmem2 promotes cell-matrix interactions by influencing ECM 
organization and DGC modification   
Together, our data establish Tmem2 as a previously unappreciated 
player in the cell-matrix interactions that control muscle morphogenesis.  
Tmem2 influences two distinct elements that enforce muscle fiber attachment: 
ECM deposition and CMAC composition.  Since reduced laminin deposition 
interferes with fiber attachment (Goody et al., 2010; Hall et al., 2007; Jacoby et 
al., 2009; Snow et al., 2008b), it is likely that the ECM disruption in MZtmem2 
mutants contributes to their muscle defects.  The onset of fiber detachment in 
MZtmem2 mutants corresponds to the timeframe when laminin enrichment 
normally begins at the somite boundary (Crawford et al., 2003).  Furthermore, 
ECM disorganization could explain the cardia bifida in MZtmem2 mutants 
(Arrington and Yost, 2009; Garavito-Aguilar et al., 2010; Trinh and Stainier, 
2004).  In addition, since DGC glycosylation promotes its engagement of the 
ECM (Sciandra et al., 2013), hypoglycosylation of αDG could also contribute to 
the fiber detachments in MZtmem2 mutants, as seen in embryos with reduced 
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glycosyltransferase activity (Kawahara et al., 2010; Lin et al., 2011).   
Do the ECM and CMAC features of the MZtmem2 phenotype represent 
two separate functions of Tmem2, or are these roles of Tmem2 interrelated?  
Although ECM composition is not likely to have a direct impact on αDG 
glycosylation, prior studies have found that laminin organization can be 
influenced by DGC glycosylation state (Kanagawa et al., 2005; Michele et al., 
2002).  Alternatively, Tmem2 could influence the ECM and DGC through two 
independent mechanisms.  In this regard, it is intriguing that the Tmem2 
ectodomain can fulfill some, but not all, aspects of Tmem2 function: although 
the ectodomain can improve fiber attachment in MZtmem2 mutants, it seems 
less effective than full-length Tmem2, and it cannot rescue αDG glycosylation.  
Thus, our data suggest that Tmem2 can function in the extracellular 
environment, consistent with our prior finding that myocardial expression of 
tmem2 can non-autonomously rescue MZtmem2 endocardial phenotypes 
(Totong et al., 2011).  At the same time, our results suggest that distinct 
subcellular locations of Tmem2 function are relevant to its influence on 
posttranslational modification of αDG.  We therefore favor a model in which 
independent activities of Tmem2, affecting ECM organization and αDG 
glycosylation, collaborate to enforce muscle fiber attachment.  
The influence of Tmem2 on muscle fiber attachment suggests an 
interesting link to the etiology of muscular dystrophy.  In particular, Tmem2 
may be relevant to the set of congenital muscular dystrophies known as 
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dystroglycanopathies, which feature aberrant glycosylation of αDG (Muntoni et 
al., 2008; Wells, 2013).  Mutations in 18 genes have been shown to cause 
dystroglycanopathies, and several of these genes encode characterized or 
putative glycosyltransferases (Bouchet-Séraphin et al., 2015; Godfrey et al., 
2011).  However, as many as half of the dystroglycanopathy patients 
examined do not present mutations in known genes, and the process of post-
translational modification of the DGC is not fully understood.  Future 
elucidation of the molecular mechanisms of Tmem2 function is likely to provide 
valuable perspective on its relationship to dystroglycanopathy, as well as 
further insight into how ECM organization and CMAC composition both 
contribute to the stability of cell-matrix interactions during muscle 
development.     
 
 
MATERIALS AND METHODS 
 
Zebrafish  
To obtain MZtmem2 mutant embryos, we used germline replacement to 
generate chimeric female fish with a tmem2sk38 mutant germline, and we bred 
these females to male tmem2 heterozygotes, as previously described (Totong 
et al., 2011).  MZtmem2 mutants were distinguished from their Mtmem2 
siblings by morphological criteria and PCR genotyping (Totong et al., 2011).  
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All zebrafish work followed IACUC-approved protocols. 
 
Immunofluorescence 
Wholemount immunofluorescence was performed as previously described 
(Goody et al., 2012), using rhodamine phalloidin (Invitrogen, R415) and 
antibodies listed in Table 2.S4.  For cryosections, embryos were fixed 
overnight in 4% paraformaldehyde at 4°C, followed by cryoprotection, 
mounting, sectioning, staining, and treatment with SlowFade Gold with DAPI 
(Invitrogen), as described previously (Garavito-Aguilar et al., 2010).  
 
In situ hybridization 
In situ hybridization for ptc1 (ZDB-GENE-980526-196), ehh (ZDB-GENE-
980526-135), and myl7 (ZDB-GENE-991019-3) was performed as previously 
described (Yelon et al., 1999).   
Injection 
Embryos were injected at the one-cell stage with 200 pg mRNA encoding 
either full-length Tmem2 (Totong et al., 2011) or a modified version of the 
Tmem2 ectodomain.  In this fusion protein, we replaced the first 103 amino 
acids of Tmem2, corresponding to its cytoplasmic and transmembrane 
domains, with the first 23 amino acids of zebrafish Sonic Hedgehog (Ekker et 
al., 1995), which serve as a signal to target the ectodomain for secretion.   
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Imaging 
Fluorescent images are maximal intensity projections of confocal 
reconstructions, with the exception of the single optical slices shown in Fig. 
2.3A-E.  Z-stacks containing 120-140 slices (0.5 micron thick) were acquired 
with a 25x water objective on a Leica SP5 microscope and analyzed with 
Imaris software (Bitplane).  Additional images were captured using Zeiss 
Axiozoom and Axioimager microscopes with a Zeiss AxioCam and processed 
using Zeiss AxioVision and Adobe Creative Suite.  
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Figure 2.1. Disrupted muscle fiber attachment in MZtmem2 mutants  
(A-F) Lateral views display somite and notochord morphology at 24 hours post-
fertilization (hpf).  Mtmem2 (A-C) control siblings are indistinguishable from wild-type, 
and MZtmem2 mutants (D-F) exhibit a normal number of somites (32 somites in A,D).  
However, MZtmem2 mutants (D-F) have U-shaped (E), rather than chevron-shaped 
(B), somites, and a slightly narrow notochord (bracket, F). (G-K) Immunofluorescence 
reveals muscle fiber organization, using phalloidin (red) to recognize both fast and 
slow fibers and F59 (green) to recognize slow fibers; lateral views with dorsal up 
(except for transverse views in G4-I4) at 26 hpf (G-I) or 5 days post-fertilization (dpf) 
(J,K).  MZtmem2 mutants display muscle fiber detachment (H1-H3), whereas 
Mtmem2 siblings exhibit normal fiber attachment (G1-G3).  Attachment can be 
rescued in MZtmem2 mutants by injection of wild-type tmem2 mRNA (I1-I3; n=6/7).  
The severity of detachment in MZtmem2 mutants increases over time (K), indicating 
the importance of tmem2 for the maintenance of muscle fiber attachment.  (L) Bar 
graph compares average prevalence of fiber attachment in somites at 48 hpf; error 
bars indicate s.e.m.  F59+ fibers were counted within 11 somites of multiple embryos 
(Mtmem2, n=6; MZtmem2, n=4; Mtmem2 expressing full-length tmem2 ("+full"), n=6; 
MZtmem2+full, n=8; Mtmem2 expressing tmem2 ectodomain ("+ecto"), n=2; 
MZtmem2+ecto, n=5).  Introduction of either full-length Tmem2 or the Tmem2 
ectodomain into MZtmem2 mutants caused improvement in fiber attachment.  
Asterisks indicate significant differences from MZtmem2 (Student's t-test; p<0.001 for 
full, p<0.05 for ecto).  See also Table 2.S1.   
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Figure 2.2. Aberrant ECM organization at the MTJ in MZtmem2 mutants   
(A-H) Immunofluorescence indicates localization of laminin (red, A-D) and fibronectin 
(red, E-H) relative to slow muscle fibers, labeled with F59 (green, A-H); lateral views, 
dorsal up, at 20 so (A,B,E,F), and 26 hpf (C,D,G,H).  (A-D) Laminin is present at the 
MZtmem2 MTJ by 20 so (B), although it appears disorganized compared to what is 
seen in Mtmem2 siblings (A).  By 26 hpf, laminin deposition appears diminished at 
the MZtmem2 MTJ (D).  (E-H) Fibronectin fibrillogenesis is evident at the MZtmem2 
MTJ at 20 so (F), albeit in an aberrant pattern that echoes the morphology of the 
MZtmem2 somites.  By 26 hpf, when much of the fibronectin has been degraded at 
the Mtmem2 MTJ (G), fibronectin levels appear increased in MZtmem2 mutants (H), 
particularly where fibers are detached.  However, nearly all of this fibronectin 
degrades in MZtmem2 mutants by 40 hpf (data not shown).   
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Figure 2.3. ECM disorganization accompanies cardia bifida in MZtmem2 
mutants 
(A-E) Immunofluorescence illustrates laminin (green; B,C) and fibronectin (green, 
D,E) localization near the myocardium (marked by tropomyosin (red)); transverse 
sections, dorsal up, at 20 so, with DAPI (magenta).  Dashed rectangle in A indicates 
the right cardiac primordium, closer views of which are shown in B-E. (B) During 
cardiac fusion, laminin deposition is normally evident on the basal side of the 
myocardium (arrowhead, B2) (Arrington and Yost, 2009).  (C) In MZtmem2 mutants, 
laminin organization appears severely compromised (arrowhead, C2), and a discrete 
basal layer does not form.  (D,E) Fibronectin fibrils normally underlie the myocardium 
during cardiac fusion (arrowhead, D2) (Trinh and Stainier, 2004), but fibronectin 
deposition appears irregular and disorganized in MZtmem2 mutants (arrowhead, E2).   
(F-K) Expression of myl7 at 24 hpf in Mtmem2 (F,I) and MZtmem2 (G,H,J,K) siblings; 
dorsal views, rostral up.  By 24 hpf, the heart tube assembles normally in Mtmem2 
siblings (F), but MZtmem2 mutants typically exhibit cardia bifida (G).  Occasionally, 
MZtmem2 mutants display partial cardiac fusion (H, Table 2.S2).  Injection of tmem2 
mRNA rescues cardiac fusion (K) in MZtmem2 mutants and can even restore heart 
tube formation (J; Table 2.S2), but does not affect heart formation in Mtmem2 siblings 
(I; Table 2.S2).   
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Figure 2.4. Abnormal distribution and glycosylation of CMAC components in 
MZtmem2 mutants   
(A-G) Immunofluorescence shows localization of paxillin (green; A,B), pFAK [pY397] 
(red; C,D), βDG (blue; E-G), and glycosylated αDG (green; E-G) relative to muscle 
fibers, marked with phalloidin (red; A,B,E-G) or the antibody F310 (green; C,D); lateral 
views, dorsal up, at 26 hpf.  (A-D) Both paxillin (B2) and pFAK (D2) are recruited to 
the MZtmem2 MTJ.  However, compared to the concentrated and robust localization 
in Mtmem2 siblings (A2,C2), paxillin appears disorganized (B2), and pFAK levels are 
diminished (D2).  (E-G) The antibody IIH6, which recognizes a glycosylated epitope of 
αDG within its laminin-binding site (Ervasti and Campbell, 1993), detects αDG at the 
MTJ in Mtmem2 siblings (E2), but detects only trace amounts of glycosylated αDG at 
the MZtmem2 MTJ (F2, Table 2.S3).  In contrast, βDG is readily detectable at the 
MZtmem2 MTJ (F3).  αDG glycosylation can be rescued in MZtmem2 mutants by 
injection of tmem2 mRNA (G2, Table 2.S3). (H) Bar graph compares immunostaining 
intensity for glycosylated αDG, relative to levels of βDG, at the MTJ at 26 hpf; error 
bars indicate s.e.m.  For each condition, we measured the mean pixel intensity (MPI) 
of immunostaining at 5 different MTJs in each of 3 representative embryos; see also 
Fig. 2.S5.  Introduction of full-length Tmem2, but not the Tmem2 ectodomain, caused 
improvement in αDG glycosylation in MZtmem2 mutants.  Asterisk indicates 
significant difference from MZtmem2 (Student's t-test; p<0.005).   
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Figure 2.S1. Hedgehog signaling and notochord differentiation are intact in 
MZtmem2 mutants   
(A-D) In situ hybridization depicts expression of ptc1 at 24 hpf (A,C) or ehh at 30 hpf 
(B,D) in Mtmem2 (A,B) and MZtmem2 (C,D) siblings, lateral views, anterior at left.  
A2-D2 show closer views of regions outlined by white rectangles in A1-D1.  (A,C) 
Expression of ptc1 serves as a reporter of Hedgehog signaling.  Loss of Hedgehog 
signaling causes formation of U-shaped somites (Lewis et al., 1999; Schauerte et al., 
1998; van Eeden et al., 1996), but Hedgehog signal transduction seems relatively 
robust in MZtmem2 mutants.  (B,D) Notochord maturation is accompanied by loss of 
expression of ehh, a chordamesoderm marker (Parsons et al., 2002b; Stemple, 
2005).  As notochord differentiation proceeds from anterior to posterior, ehh is visible 
only at the caudal end of the notochord by 30 hpf (B).  The progression of 
differentiation is relatively normal in MZtmem2 mutants (D), although the slightly 
increased extent of ehh expression that remains at 30 hpf suggests a slight delay.   
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Figure 2.S2. Initial formation of somite borders appears normal in MZtmem2 
mutants 
(A-F) Immunofluorescence indicates localization of fibronectin (red) relative to β-
catenin (green) at 12 so (A,B) and 15 so (C-F).  (A,B) Dorsal views, anterior to the 
left, of the right myotome show fibronectin localization at somite boundaries.  In 
MZtmem2 mutants (B2), fibronectin is deposited at each somite boundary, in a 
pattern comparable to that seen in Mtmem2 siblings (A2).  Additionally, muscle 
precursor cells at the borders of MZtmem2 somites exhibit characteristic elongation 
indicative of the formation of epithelial somite boundaries (Henry et al., 2005) (B3, 
arrow), just as in Mtmem2 siblings (A3, arrow).  These results suggest that the initial 
formation of somite boundaries proceeds normally in MZtmem2 mutants.  (C,D) 
Lateral views, dorsal up, display fibronectin localization at somite boundaries at 15 so, 
when the earliest aberrations in fibronectin organization appear in MZtmem2 mutants.  
In MZtmem2 mutants (D), fibronectin is present at somite boundaries, but seems 
disorganized, in contrast to the sharply defined fibronectin deposition present in 
Mtmem2 siblings (C).  (E,F) Dorsal views, anterior to the left, indicate that fibronectin 
is present at somite boundaries at 15 so in MZtmem2 mutants (F), as it is in Mtmem2 
siblings (E).  E2 and F2 show closer views of regions outlined by white rectangles in 
E1 and F1.   
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Figure 2.S3. Disruption of fast muscle fiber attachment in MZtmem2 mutants 
(A-D) Immunofluorescence reveals muscle fiber organization, using phalloidin (red in 
A,B) to recognize both fast and slow fibers, F59 (green in A,B) to recognize slow 
fibers (Devoto et al., 1996), and F310 (green in C,D) to recognize fast fibers (Nord et 
al., 2014); lateral views, dorsal up, at 26 hpf.  (A,B) In addition to exhibiting 
detachment of F59+ slow muscle fibers (B1; see also Fig. 2.1H), MZtmem2 mutants 
display detachment of F59- fast muscle fibers (arrows, B2), in contrast to the attached 
fibers observed in Mtmem2 siblings (A).  (C,D) Similarly, MZtmem2 mutants (D) 
display detachment of F310+ fast muscle fibers (arrow, D2), in contrast to the 
attachment seen in Mtmem2 siblings (C).  C2 and D2 show closer views of regions 
outlined by white rectangles in C1 and D1. 
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Figure 2.S4. Impairment of muscle fiber organization in zygotic tmem2 mutants   
(A-D) Immunofluorescence with F59 (green) reveals slow muscle fiber organization; 
lateral views with dorsal up at 48 hpf.  At this stage, MZtmem2 mutants (B) exhibit 
detachment and disorganization of slow muscle fibers, in contrast to the normal 
attachment seen in their Mtmem2 siblings (A).  Although we have not observed 
muscle fiber detachment in zygotic tmem2 (Ztmem2) mutants at 24 hpf (data not 
shown), we have found fiber detachment and disorganization in some Ztmem2 
mutants (D) by 48 hpf (n=4 out of 33 Ztmem2 mutants examined).  (E,F) 
Immunofluorescence detecting laminin (red) deposition at the MTJ reveals somite 
shape defects in Ztmem2 mutants.  In wild-type (E) and Ztmem2 (F) sibling embryos, 
somite shape was evaluated by measuring the angle formed at the MTJ.  White dots 
represent examples of the reference points chosen at the horizontal myoseptum, the 
dorsal edge of the MTJ, and the ventral edge of the MTJ; dashed lines represent the 
angle measured using ImageJ software.  (G) Bar graph compares average angles 
formed at the MTJ in wild-type and Ztmem2 embryos at 24 hpf and 48 hpf (in wild-
type, n=85 at 24 hpf and n=75 at 48 hpf; in Ztmem2, n=52 at 24 hpf and n=154 at 48 
hpf).  Error bars indicate s.d., and asterisks indicate a significant difference from wild-
type (Student's t-test; p<0.0001).  Somite shapes in Ztmem2 mutants become less 
chevron-shaped and more U-shaped over time, presumably as maternal supplies of 
tmem2 are depleted and muscle fiber defects accumulate. 
 
	  	  
52 
 
 
 
Figure 2.S5. Quantification of intensity of immunostaining for dystroglycan at 
the MTJ  
(A) Confocal reconstruction depicts immunostaining for glycosylated αDG (A1) and 
βDG (A2) in a Mtmem2 embryo at 26 hpf; lateral view, dorsal up.  To quantify the 
intensity of immunostaining through the entire depth of the confocal stack, we used 
Imaris software to rotate each reconstruction 30 degrees toward the right and then 
used ImageJ software to measure the mean pixel intensity (MPI) within an oval-
shaped region of interest positioned at the MTJ.  Ovals of the same size and in the 
same position were used to measure MPI for both glycosylated αDG and βDG (ovals 
in A1,A2).  (B) Bar graph compares MPI of immunostaining for glycosylated αDG at 
the MTJ at 26 hpf; error bars indicate s.e.m.  For each condition, we measured the 
MPI at 5 different MTJs in each of 3 representative embryos (Mtmem2: 2 embryos 
presenting normal staining and 1 embryo presenting traces of staining; MZtmem2: 2 
embryos presenting traces of staining and 1 embryo presenting no staining; Mtmem2 
+ full: 2 embryos presenting normal staining and 1 embryo presenting traces of 
staining; MZtmem2 + full: 3 embryos presenting normal staining; Mtmem2 + ecto: 3 
embryos presenting normal staining; MZtmem2 + ecto: 2 embryos presenting traces 
of staining and 1 embryo presenting no staining).  Introduction of full-length Tmem2, 
but not the Tmem2 ectodomain, caused evident improvement in aDG glycosylation in 
MZtmem2 mutants.  Asterisk indicates significant difference from MZtmem2 
(Student's t-test; p<0.01).   See also Fig. 2.4H and Table 2.S3. 
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Table 2.S1. Rescue of muscle fiber attachment by injection of tmem2 mRNA 
 
 
        Muscle fiber phenotype at 48 hpf 
        many 
detached 
few 
detached 
all  
attached 
Mtmem2 uninjected   8/8 (100%) 
MZtmem2 uninjected 9/9 (100%)   
Mtmem2 full-length   7/7 (100%) 
MZtmem2 full-length 1/17 (6%) 1/17 (6%) 15/17 (88%) 
Mtmem2 ectodomain  1/2 (50%) 1/2 (50%) 
MZtmem2 ectodomain 2/8 (25%) 3/8 (25%) 3/8 (37.5%) 
 
 
Summary of 3 independent experiments evaluating whether injection of mRNA 
encoding either full-length Tmem2 or the Tmem2 ectodomain can rescue the muscle 
fiber detachment defects in MZtmem2 mutants.  Genotype (Mtmem2 and MZtmem2) 
and mRNA injected (uninjected, full-length, or ectodomain) are provided for each set 
of embryos.  Data indicate the fraction of examined embryos displaying severe 
muscle fiber detachment, a small number of detached fibers, or normal fiber 
attachment.  For each embryo, we examined 11 somites on the left side of the 
myotome, using immunofluorescence with F59 and phalloidin to reveal muscle fiber 
organization.  Embryos were classified as "many detached" if fiber detachment was 
evident in all 11 somites examined and as "few detached" if fiber detachment was 
evident in 5 or fewer somites.  In a subset of these embryos, we counted the numbers 
of attached and detached F59+ fibers within the 11 somites examined, and this 
quantification is presented in Fig. 2.1L.  Full-length Tmem2 and the Tmem2 
ectodomain are both capable of rescuing muscle fiber attachment in MZtmem2 
mutants, although full-length Tmem2 seems to rescue more efficiently.  
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Table 2.S2. Rescue of cardiac fusion by injection of tmem2 mRNA 
 
 
  Cardiac fusion phenotype at 24 hpf 
  Cardia 
Bifida 
partial 
fusion 
cardiac 
ring 
heart 
tube 
Mtmem2 uninjected    8/8 (100%) 
MZtmem2 uninjected 19/23 (83%) 4/23 (17%)   
Mtmem2 full-length    27/27 (100%) 
MZtmem2 full-length   4/18 (22%) 14/18 (78%) 
Mtmem2 ectodomain  1/13 (8%)  12/13 (92%) 
MZtmem2 ectodomain 2/28 (7%) 7/28 (25%) 17/28 (61%) 2/28 (7%) 
 
 
Summary of 4 independent experiments evaluating whether injection of mRNA 
encoding either full-length Tmem2 or the Tmem2 ectodomain can rescue the cardiac 
fusion defects in MZtmem2 mutants.  Genotype (Mtmem2 and MZtmem2) and mRNA 
injected (uninjected, full-length, or ectodomain) are provided for each set of embryos.  
Cardiac phenotypes were assessed through in situ hybridization for myl7, as in Fig. 
2.3F-K.  Data indicate the fraction of examined embryos displaying cardia bifida (as in 
Fig. 2.3G), partial fusion at the posterior end of the cardiac primordia (as in Fig. 2.3H), 
fusion to form a ring of cardiomyocytes (as in Fig. 2.3K), or normal heart tube 
assembly (as in Fig. 2.3J).  Full-length Tmem2 and the Tmem2 ectodomain are both 
capable of rescuing cardiac fusion in MZtmem2 mutants, although full-length Tmem2 
seems to rescue more efficiently.  
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Table 2.S3. Rescue of αDG glycosylation by injection of tmem2 mRNA 
 
                                IIH6 staining at 26 hpf 
  no 
staining 
traces of 
staining 
normal 
staining 
Mtmem2 uninjected  4/26 (15%) 22/26 (85%) 
MZtmem2 uninjected 18/32 
(56%) 
14/32 
(44%)  
Mtmem2 full-length  1/9 (11%) 8/9 (89%) 
MZtmem2 full-length  2/13 (15%) 11/13 (85%) 
Mtmem2 ectodomain   5/5 (100%) 
MZtmem2 ectodomain 1/7 (14%) 6/7 (86%)  
 
 
Summary of 3 independent experiments evaluating whether injection of mRNA 
encoding either full-length Tmem2 or the Tmem2 ectodomain can rescue αDG 
glycosylation at the MTJ in MZtmem2 mutants.  Genotype (Mtmem2 and MZtmem2) 
and mRNA injected (uninjected, full-length, or ectodomain) are provided for each set 
of embryos.  αDG glycosylation was assessed through immunostaining of with the 
antibody IIH6, as in Fig. 2.4E’-G’.  Data indicate the fraction of examined embryos 
displaying no IIH6 staining at the MTJ, trace amounts of IIH6 staining at the MTJ (as 
in Fig. 2.4F’), or normal IIH6 staining at the MTJ (as in Fig. 2.4E’ and 2.4G’).  In a 
subset of these embryos, we measured the intensity of IIH6 staining at 5 different 
MTJs in each of 3 representative embryos; the results of this quantitative analysis are 
presented in Figs. 2.4H and 2.S5.  Full-length Tmem2 is capable of rescuing αDG 
glycosylation at the MTJ in MZtmem2 mutants, whereas introduction of the Tmem2 
ectodomain is not sufficient to rescue normal levels of glycosylated amutants, 
whereas introduction of the Tmem2 ectodomain is not sufficient to rescue normal 
levels of glycosylated αDG in this context. 
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Table 2.S4. Antibodies used for immunofluorescence 
 
 
 Antigen Reagent Vendor Dilution 
Primary 
antibodies 
Myosin heavy 
chain 
Mouse 
monoclonal (F59) 
Developmental 
Studies Hybridoma 
Bank (supernatant) 
1:10 
 Laminin Rabbit polyclonal Sigma  
(#L9393) 
1:100 
 Fibronectin Rabbit polyclonal Sigma  
(#F3648) 
1:100 
 b-catenin Mouse 
monoclonal 
(15B8) 
Sigma  
(#C7207) 
1:500 
 Tropomyosin Mouse 
monoclonal (CH1) 
Developmental 
Studies Hybridoma 
Bank (supernatant) 
1:10 
 Paxillin Mouse 
monoclonal (349) 
BD Biosciences  
(#612405) 
1:50 
 FAK [pY397] Rabbit polyclonal Invitrogen  
(#44-624G) 
1:50 
 Myosin heavy 
chain 
Mouse 
monoclonal 
(F310) 
Developmental 
Studies Hybridoma 
Bank (supernatant) 
1:10 
 a-dystroglycan Mouse 
monoclonal (IIH6-
C4) 
Santa Cruz 
Biotechnology  
(#sc-73586) 
1:50 
 b-dystroglycan Mouse 
monoclonal 
(43DAG1/8D5) 
Novocastra  
(#NCL-b-DG) 
1:50 
Secondary 
antibodies 
Rabbit IgG Goat polyclonal;  
Alexa Fluor 594 
Molecular Probes  
(#A11012) 
1:200 
 Rabbit IgG Goat polyclonal;  
Alexa Fluor 647 
Molecular Probes  
(#A21245) 
1:200 
 Mouse IgG1 Goat polyclonal;  
FITC 
Southern 
Biotechnology  
(#1070-02) 
1:100 
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Chapter 2, in full, is a reprint of the material as it appears in: Lucile 
Ryckebusch, Lydia Hernandez, Carole Wang, Jenny Phan, Deborah Yelon. 
(2016). Tmem2 regulates cell-matrix interactions that are essential for muscle 
fiber attachment. Development 143(16): p.2965-2972.  Lydia Hernandez is a 
primary researcher/author on this paper.  Lydia Hernandez contributed to 
designing the experiments, conducting research, interpreting results, and 
writing the manuscript presented in Chapter 2.  Lucile Rycebusch contributed 
to designing the experiments, conducting research, interpreting results, and 
writing the manuscript presented in Chapter 2.  Deborah Yelon contributed to 
designing the experiments, interpreting results, and writing the manuscript 
presented in Chapter 2.  Carole Wang and Jenny Phan performed 
experiments and analyzed data presented in Chapter 2.  
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Chapter 3: Tmem2 restricts atrioventricular canal differentiation by 
regulating degradation of hyaluronic acid 
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ABSTRACT 
Atrioventricular valve development relies upon the precisely defined 
dimensions of the atrioventricular canal (AVC).  Transmembrane protein 2 
(Tmem2) is a key player in this process: in zebrafish, zygotic tmem2 (Ztmem2) 
mutants display ectopic AVC characteristics alongside excess hyaluronic acid 
(HA) deposition.  However, the molecular mechanisms of Tmem2 function 
during AVC differentiation remain unclear.  To address this, we performed a 
structure-function analysis and determined that the extracellular domains of 
Tmem2 are crucial for its role in restricting AVC boundaries.  These same 
domains are also essential for an earlier function of Tmem2 in promoting 
cardiomyocyte movement during cardiac fusion.  Tmem2 has recently been 
shown to act as a hyaluronidase, and degradation of HA can restore the 
restriction of AVC differentiation in Ztmem2 mutants.  Furthermore, a residue 
vital for Tmem2 hyaluronidase activity is also critical for delimiting AVC 
differentiation but is not essential during cardiac fusion.  Overall, these data 
support a model in which Tmem2 regulates AVC differentiation by controlling 
the degradation of HA and suggest that this mechanism for Tmem2 function 
could be context-dependent.  
 
 
INTRODUCTION  
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Atrioventricular valves divide the cardiac chambers and must be 
precisely patterned and spatially defined in order to insure proper blood flow.  
Atrioventricular valve development occurs after the onset of cardiac function 
and within an environment of ongoing morphological changes in the heart.  
The primitive heart begins as a linear tube comprised of two layers: an inner, 
vascular layer, the endocardium, and an outer layer of muscle, the 
myocardium.  Between these two layers is a lining of extracellular matrix 
(ECM) known as the cardiac jelly.  At the junction between the ventricle and 
the atrium, characteristic morphological changes distinguish a region referred 
to as the atrioventricular canal (AVC).  Cells within the AVC must differentiate 
and undergo specific structural changes, ultimately forming swellings of tissue 
known as endocardial cushions (Markwald et al., 1977).  Eventually, through 
extensive tissue remodeling, endocardial cushions give rise to the valve 
leaflets of the mature atrioventricular valve (Armstrong and Bischoff, 2004).   
Although the precise mechanisms for coordination of AVC 
differentiation are unclear, we do understand that appropriately confined Wnt 
signaling is required to trigger specific changes in the AVC myocardium and 
endocardium.  In zebrafish, a defined region of Wnt signaling activity 
delineates the AVC (Moro et al., 2012), and aberrant expansion of Wnt 
signaling leads to ectopic AVC differentiation.  For example, in zebrafish apc 
mutants, which exhibit constitutively active Wnt signaling due to persistent 
nuclear presence of β-catenin, expression of AVC molecular markers, such as 
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bmp4, is expanded and excess endocardial cushion formation occurs 
(Hurlstone et al., 2003).  Conversely, attenuation of Wnt signaling, either 
through overexpression of apc or the Wnt antagonist Dkk1, reduces 
expression of bmp4 in the AVC (Verhoeven et al., 2011) and inhibits formation 
of endocardial cushions (Hurlstone et al., 2003).  These findings suggest that 
Wnt signaling is essential for AVC differentiation and demonstrate that bmp4 
expression is induced downstream of Wnt signaling.  The upstream factors 
that regulate Wnt signaling, however, remain undefined. 
Our earlier work has identified tmem2 as a key player in the process of 
delimiting AVC differentiation.  Zebrafish tmem2 mutants display expansion of 
AVC molecular markers as well as a failure to appropriately restrict formation 
of endocardial cushions (Smith et al., 2011; Totong et al., 2011).  These 
defects are accompanied by increased deposition of the glycosaminoglycan 
hyaluronic acid (HA), a major component of the cardiac ECM, between the 
endocardium and the myocardium (Smith et al., 2011).  In addition to its role in 
restricting AVC differentiation, tmem2 has been implicated in vessel sprouting 
(De Angelis et al., 2017), promoting cardiac fusion (Totong et al., 2011), and 
stabilizing muscle fiber attachments (Ryckebusch et al., 2016), and aberrant 
ECM deposition has been observed in each of these contexts in tmem2 
mutants.  Taken together, these observations prompt the hypothesis that 
tmem2 may control cardiovascular and muscle morphogenesis through 
regulation of the ECM. 
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Despite recent work examining the various activities of Tmem2, 
relatively little is known about how Tmem2 structure informs its various 
physiological functions.  Tmem2 is a single-pass type II transmembrane 
protein with a short cytoplasmic portion and an extended extracellular region 
(Smith et al., 2011; Totong et al., 2011).  Within the extracellular region, there 
are four recognized domains – a G8 domain, a Pander-like Tmem2 domain 
(PLT), a series of parallel beta helix (PbH1) repeats, and a second Pander-like 
(PL) domain.  The functions of these types of domains have been defined in 
the context of other proteins.  For example, Pander-like domains have been 
identified in proteins involved in glycosylation, apoptosis, and metastasis (Cao 
et al., 2003; Johansson et al., 2013; Pereira et al., 2014; Yoshida et al., 2013).  
The G8 domain of KIAA1199, a protein with structural similarities to Tmem2, 
can bind the EGF receptor and activate EGF signaling (Shostak et al., 2014).  
PbH1 repeats typically form pectin lyase folds with enzymatic activity capable 
of degrading polysaccharides (Henrissat et al., 1995; Mayans et al., 1997).  At 
the onset of our studies, it was unknown whether or how any of these domains 
were relevant to the activities of Tmem2.   
Recently, mammalian cell culture studies have identified Tmem2 as a 
cell surface hyaluronidase capable of depolymerizing large HA molecules 
down to ~5 kDa fragments (Yamamoto et al., 2017).  Moreover, the 
hyaluronidase activity of Tmem2 appears to be important to its function in the 
context of angiogenesis.  Zebrafish tmem2 mutants exhibit decreased 
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intersegmental vessel (ISV) sprouting as well as increased HA deposition 
surrounding these vessels, and reduction of HA levels in tmem2 mutants via 
treatment with exogenous hyaluronidase improved their ISV sprouting (De 
Angelis et al., 2017).  Together, these findings support the idea that Tmem2 
can control morphogenetic processes by regulating degradation of HA.   
Does the ability of Tmem2 to function as a hyaluronidase also underlie 
its influence on the restriction of AVC differentiation?  This seems like a 
promising model in light of the excess HA deposition observed in the tmem2 
mutant heart (Smith et al., 2011).  In addition, mutations affecting HA 
synthesis are known to result in defective AVC formation.  In mice, loss of 
function of Hyaluronan Synthase 2 (Has2), which synthesizes HA, inhibits 
formation of endocardial cushions (Camenisch et al., 2000).  Conversely, 
zebrafish dicer mutants have increased has2 expression, resulting in excess 
HA deposition and ectopic endocardial cushion differentiation (Lagendijk et al., 
2011).  Knockdown of has2 is able to rescue this phenotype and results in 
proper AVC restriction (Lagendijk et al., 2011).  While it is clear that the levels 
of HA deposition are important for appropriate AVC development, the 
functional relationship between Tmem2, AVC differentiation, and HA 
catabolism has remained unexamined.   
Here, we show that the four identified domains within the Tmem2 
extracellular region are critical for its roles in AVC restriction, cardiac fusion, 
and muscle fiber maintenance.  Examination of the subcellular localization of 
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Tmem2 suggests that these domains are likewise important for correct 
trafficking of Tmem2 to the plasma membrane.  Finally, our results show that 
the activity of Tmem2 as a hyaluronidase is critical for restricting AVC 
differentiation.  Intriguingly, however, we demonstrate that this same activity is 
inessential to the role of Tmem2 in promoting cardiac fusion.  Overall, through 
structure-function analysis of Tmem2, we identify Tmem2 as a regulator of HA 
degradation in the context of AVC development and suggest that this 
mechanism for Tmem2 function could be context-dependent. 
 
 
RESULTS 
 
Extracellular domains of Tmem2 are critical for proper AVC 
differentiation 
To gain insight into the molecular mechanism by which Tmem2 restricts 
AVC differentiation, we sought to identify which domains of Tmem2 are critical 
for its function.  For this structure-function analysis, we have examined 
whether altered forms of Tmem2 – variants either replacing or lacking 
identified domains (Fig. 3.1) – could rescue aspects of the tmem2 mutant 
phenotype.  All constructs used here are fusion proteins with Gfp attached to 
the C-terminus, since in prior studies, we have shown that expression of 
tmem2-gfp rescues tmem2 mutant defects as effectively as expression of 
tmem2 without a C-terminal tag (Totong et al., 2011).  Using these constructs, 
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we have examined which domains of Tmem2 are required for regulating the 
expression pattern of bmp4, a molecular marker of the AVC myocardium 
(Hurlstone et al., 2003).  In wild-type embryos at 48 hours post fertilization 
(hpf), concentrated expression of bmp4 is evident in a confined territory at the 
AVC (Fig. 3.2A).  In contrast, zygotic tmem2 (Ztmem2) mutants fail to 
appropriately delimit bmp4 expression and instead exhibit bmp4 expression 
broadly throughout the ventricle (Totong et al., 2011) (Fig. 3.2B).  Injection of 
mRNA encoding full-length tmem2-gfp at the one-cell stage is able to rescue 
the bmp4 expression pattern in Ztmem2 mutants (Fig. 3.2D; Table 3.1).  We 
therefore examined whether expression of tmem2 variants could rescue 
mutant defects as effectively as expression of full-length tmem2.   
We wondered whether the cytoplasmic and transmembrane domains of 
Tmem2 were required for its activity, perhaps enabling Tmem2 to function as a 
signaling molecule.  To address this question, we created the variant htrc-
tmem2, in which the cytoplasmic and transmembrane domains of Tmem2 
have been replaced with those from the human transferrin receptor, another 
type II transmembrane protein (Fig. 3.1).  Expression of htrc-tmem2 can 
rescue the bmp4 expression pattern in Ztmem2 mutants, albeit not as robustly 
as full-length tmem2 does (Table 3.1).  This result indicated that the Tmem2 
cytoplasmic domain is not essential for its activity during AVC differentiation 
and suggested that the primary function of Tmem2 might take place outside of 
the cell.  To test this idea, we examined the effectiveness of a secreted 
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version of the Tmem2 ectodomain, sc-tmem2 (Fig. 3.1).  Expression of sc-
tmem2 in tmem2 mutants could rescue the bmp4 expression pattern, but not 
as effectively as htrc-tmem2 or full-length tmem2 (Table 3.1).  These findings 
suggest that membrane localization of Tmem2 is valuable, although not 
absolutely required, for its function in AVC restriction.  Having demonstrated 
that the Tmem2 ectodomain is functional, we focused more closely on the 
extracellular region and examined variants of Tmem2 that lack individual 
extracellular domains. Notably, Tmem2 variants lacking the G8, PLT, PbH1, or 
PL domains (Fig. 3.1) could not rescue the bmp4 phenotype in Ztmem2 
mutants (Fig. 3.2F; Table 3.1).  Taken together, these data suggest that the 
extracellular domains of Tmem2 are critical for its function to delimit AVC 
differentiation.   
 
Extracellular domains of Tmem2 are critical for promoting cardiac fusion  
Next, we wondered whether the extracellular domains that are 
important for the role of Tmem2 during AVC differentiation are also important 
for the activity of Tmem2 in other developmental contexts.  Strikingly, 
maternal-zygotic tmem2 (MZtmem2) mutants do not complete cardiac fusion 
(Ryckebusch et al., 2016; Totong et al., 2011): cardiomyocytes are 
significantly hindered in their movement toward the midline and instead remain 
in bilateral clusters (Fig. 3.3B) or only partially fuse at the midline by 24 hpf 
(Fig. 3.3C).  In contrast, maternal tmem2 (Mtmem2) mutants form primitive 
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heart tubes (Fig. 3.3A) and are indistinguishable from wild-type embryos.  
Similar to what we observed with AVC differentiation, expression of full-length 
tmem2 rescues the cardiac fusion defects in MZtmem2 mutants (Fig. 3.2E,F; 
Table 3.2).  Expression of htrc-tmem2 similarly rescues cardiac fusion (Fig. 
3.3H; Table 3.2), suggesting that the specific cytoplasmic and transmembrane 
domains of Tmem2 are not essential for its role in promoting cardiomyocyte 
movement.  Expression of sc-tmem2 can also rescue cell movement in 
MZtmem2 mutants, albeit not as efficiently as full-length tmem2 (Table 3.2).  
Consistent with what we observed in the context of AVC formation, these 
findings support the idea that membrane localization could be important for 
optimal Tmem2 activity.  Finally, none of the variants that include extracellular 
domain deletions were able to rescue the MZtmem2 cardiac fusion defects in 
MZtmem2 mutants (Fig. 3.3J; Table 3.2), indicating that the G8, PLT, PbH1, 
and PL domains are important for Tmem2 function during cardiac fusion, as 
well as during AVC differentiation.  
Having seen that the extracellular domains of Tmem2 are critical for its 
function during multiple aspects of cardiac morphogenesis, we next wondered 
whether these same regions are important for Tmem2 activity during skeletal 
muscle morphogenesis.  In addition to cardiac fusion defects, MZtmem2 
mutants exhibit detachment of muscle fibers from somite boundaries 
(Ryckebusch et al., 2016).  We have previously shown that full-length tmem2 
and the secreted version of the Tmem2 ectodomain (sc-tmem2) can rescue 
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muscle fiber detachment in MZtmem2 mutants (Ryckebusch et al., 2016) (Fig. 
3.S1G).  Given this, we next wanted to determine which portions of the 
ectodomain were important for the role of Tmem2 in stabilizing muscle fiber 
attachments.  Interestingly, we found that expression of tmem2 variants that 
are missing either the G8 or PL domain can rescue muscle fiber detachment in 
MZtmem2 mutants, albeit not as effectively as full-length tmem2 (Fig. 3.S1G).  
In contrast, tmem2 variants lacking either the PLT or PbH1 domains fail to 
ameliorate MZtmem2 muscle detachments (Fig. 3.S1D-F,G), suggesting that 
the PLT and PbH1 extracellular domains are the most essential for Tmem2 
function in maintaining skeletal muscle integrity during morphogenesis.   
Taken together, our results indicate that domains within the Tmem2 
extracellular region are critical for its function during multiple developmental 
contexts.  Further, our findings suggest that localization of Tmem2 to the 
plasma membrane enhances its function during both cardiac fusion and AVC 
differentiation. 
 
Non-functional Tmem2 variants fail to localize to the plasma membrane 
Having seen that localization of Tmem2 to the membrane appears to 
enhance its function, we next wanted to confirm the subcellular localization of 
our Tmem2 variants in vivo.  Through visualization of Gfp localization in live 
embryos following injection with variant mRNA, we were able to confirm the 
presence and relative stability of all Tmem2 variants (Fig. 3.4).  Consistent 
	  	  
69 
with what we have observed in our prior work, full-length Tmem2 localized to 
the plasma membrane (Totong et al., 2011) (Fig. 3.4A).  Likewise, Htrc-
Tmem2 was also visible at the membrane (Fig. 3.4B).  The secreted version of 
Tmem2, Sc-Tmem2, appeared to traffic to the extracellular region (Fig. 3.4C).  
Interestingly, none of the variants containing extracellular domain deletions 
localized to the plasma membrane (Fig. 3.4D-H), suggesting that all four of 
these domains influence Tmem2 localization.  Keeping in mind that these 
constructs fail to rescue aspects of Tmem2 function, we surmise that correct 
subcellular localization of Tmem2 is a critical component of its activity. 
 
Ztmem2 mutants exhibit excessive HA deposition  
Several pieces of evidence point to a relationship between Tmem2 
function and regulation of HA turnover.  Recent work in mammalian cells has 
identified Tmem2 as a cell surface hyaluronidase (Yamamoto et al., 2017).  
Additional work investigating the function of Tmem2 during angiogenesis 
showed that increased levels of HA accompanied the vessel sprouting defects 
observed in tmem2 mutants (De Angelis et al., 2017).  Moreover, degradation 
of HA with exogenous hyaluronidase ameliorated the tmem2 mutant 
angiogenesis defects, thus supporting the model that Tmem2 functions to 
regulate degradation of HA in vivo.  Could increases in HA levels also underlie 
the Ztmem2 cardiac defects? 
Interestingly, a different mutant allele of tmem2, wkmhu5935 (Smith et al., 
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2011), exhibits excess HA deposition between the endocardium and the 
myocardium.  Consistent with this, we find that Ztmem2sk38 mutants display 
aberrant cardiac deposition of HA.  By employing a HA binding protein (HABP) 
to visualize HA, we observed a layer of HA deposition between the 
endocardium and the myocardium of wild-type embryos at 48 hpf (Fig. 3.5A-
C).  In Ztmem2 mutants, however, we observed a dramatic increase in the 
amount of HA deposition both at the AVC and throughout the ventricle (Fig. 
3.5D-F).  Thus, our data bolster earlier findings that Tmem2 indeed constrains 
HA levels within cardiac tissue.  We also found that Ztmem2 mutants display 
excess chondroitin sulfate (CS) deposition.  Whereas CS localization is 
concentrated at the AVC in wild-type embryos (Fig. 3.S2B,C), Ztmem2 
mutants exhibit increased CS deposition at the AVC and throughout the 
ventricular chamber (Fig. 3.S2E,F).  These data suggest that Tmem2 plays an 
important role in limiting deposition of multiple components of the cardiac jelly.  
 
Tmem2 restricts AVC differentiation through HA regulation 
Given that Tmem2 functions to regulate HA degradation in other 
developmental contexts, we wondered whether the influence of Tmem2 on 
AVC differentiation might be mediated via HA degradation as well.  To test 
this, we injected hyaluronidase into the pericardial space of Ztmem2 mutant 
and wild-type sibling embryos at 30 hpf, when deposition of the cardiac jelly 
first becomes visible (Peal et al., 2009).  Control embryos were injected with 
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the same volume of PBS (Fig. 3.6A,B).  We found that hyaluronidase 
treatment improved the spatial restriction of bmp4 expression in the majority of 
mutant embryos examined (Fig. 3.6D; Table 3.3), whereas this treatment did 
not typically disrupt the bmp4 expression pattern in wild-type embryos (Fig. 
3.6C; Table 3.3).  From these results, we surmise that Tmem2 restricts AVC 
differentiation by limiting HA levels.  
Having seen this, we next wanted to determine whether Tmem2 
function influences Wnt signaling upstream of bmp4.  We used the transgenic 
zebrafish line Tg(7xTCF-Xla.Siam:GFP) (Moro et al., 2012) to visualize Wnt 
activity in both wild-type and Ztmem2 mutant embryos.  As previously 
reported, Wnt pathway activity is prominent within the wild-type AVC at 48 hpf 
(Fig. 3.7A, B) (Moro et al., 2012). Intriguingly, Wnt signaling appears to 
expand beyond the normal AVC region in Ztmem2 mutants (Fig. 3.7C,D) 
(Table 3.4).  Can manipulation of HA levels rescue the ectopic Wnt signaling in 
Ztmem2 mutants?  Indeed, hyaluronidase treatment noticeably restrained the 
expansion of Wnt signaling in the majority of Ztmem2 mutants examined (Fig. 
3.7G,H), whereas wild-type sibling embryos were mostly unaffected (Fig. 
3.7E,F) (Table 3.4).  Thus, our data suggest that constraint of HA levels by 
Tmem2 plays a critical role in appropriately restricting Wnt signaling activity to 
the AVC.  Importantly, these results provide the first evidence that Tmem2 
acts upstream of Wnt signaling to delimit AVC differentiation.          
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Tmem2 residue 267 is essential for its function in AVC restriction, but 
not for its role in cardiac fusion 
If Tmem2 is restricting AVC differentiation through HA regulation, how 
does it accomplish this?  One possibility is that Tmem2 can affect HA turnover 
directly.  In human Tmem2, residue 265 in the PLT domain has been shown to 
be critical for its activity as a hyaluronidase (Yamamoto et al., 2017).  In order 
to examine whether the ability of Tmem2 to degrade HA impacts its functions 
during cardiac morphogenesis, we altered the corresponding residue within 
zebrafish Tmem2 (R267H) (Fig. 3.1) and tested whether this variant could 
rescue tmem2 mutant phenotypes.  Strikingly, we found that expression of 
R267H did not restore a normal bmp4 expression pattern in Ztmem2 mutants 
(Fig. 3.8B, Table 3.1), nor did it seem to affect the bmp4 expression pattern in 
wild-type siblings (Fig. 3.8A, Table 3.S1).  These findings suggest that the 
ability of Tmem2 to depolymerize HA is essential for its function in spatially 
restricting AVC differentiation.   
Next, we examined whether the R267H variant was functional in the 
context of cardiac fusion.  Here, we were intrigued to see that expression of 
R267H efficiently rescues the MZtmem2 cardiac fusion defect; mutant 
embryos expressing R267H assemble primitive heart tubes as frequently as 
those expressing full-length tmem2 (Fig. 3.8D, Table 3.2).  Thus, our data 
reveal that R267H is fully functional in the context of cardiac fusion, whereas it 
is non-functional in the context of AVC differentiation.  Taken together, these 
	  	  
73 
findings indicate that the requirements for Tmem2 activity are context-
dependent.   
Following this, we were curious to see whether R267H localizes 
normally to the plasma membrane.  Interestingly, subcellular localization of 
R267H (Fig. 3.4I) does not appear similar to that of full-length Tmem2 (Fig. 
3.4A).  Rather than localize prominently to the plasma membrane, R267H 
clusters in foci within the cytoplasm.  Putting this together with our 
observations of R267H function, one can extrapolate that having a critical 
amount of Tmem2 at the plasma membrane is more essential for restricting 
AVC differentiation than it is for promoting cardiac fusion.  Overall, our findings 
support the possibility that Tmem2 has multiple mechanisms of activity. 
 
 
DISCUSSION  
 Taken together, our studies shed new light on the mechanisms that 
spatially restrict AVC differentiation.  We have demonstrated that Tmem2 is a 
key regulator of this process that functions to confine the distribution of Wnt 
signaling as well as the expression of bmp4 to the AVC.  Moreover, Tmem2 is 
needed to limit HA deposition, and it appears that this function of Tmem2 
mediates its influence over Wnt signaling and bmp4 expression.  Our results 
presented here support a model whereby Tmem2 acts at the cell surface as a 
hyaluronidase that delimits HA distribution in the cardiac ECM, thereby 
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confining both Wnt and Bmp signaling, and the consequent AVC 
differentiation, to the atrioventricular canal.   
Overall, our findings highlight the importance of appropriate HA 
regulation for correctly establishing AVC boundaries.  It remains unresolved, 
however, the precise mechanism by which Tmem2 governs HA modulation 
and, in turn, how HA influences AVC development on the molecular level.  
One intriguing possibility is that Tmem2 promotes HA depolymerization, 
perhaps so that the smaller molecular weight HA may function as a bioactive 
signaling molecule.  Indeed, it has been demonstrated that specific sizes of 
HA can induce different signaling pathways (De Angelis et al., 2017; Itano, 
2008; Jiang et al., 2005; Termeer et al., 2002).  For example, tmem2 mutant 
zebrafish exhibit VEGF signaling defects that are rescued by introduction of 
HA oligomers (o-HA) (De Angelis et al., 2017).  Additional research will be 
needed in order to determine whether it is HA deposition level or HA fragment 
size that informs AVC differentiation. 
We do note that HA is only one of several ECM components influenced 
by tmem2 function.  For instance, our previous findings revealed that 
MZtmem2 mutants display aberrant fibronectin and laminin organization 
surrounding cardiomyocytes and at myotendinous junctions (Ryckebusch et 
al., 2016).  Additionally, we see excesses of both HA and CS deposition in 
tmem2 mutant hearts.  In light of these observations, it is interesting to 
consider that Tmem2 may have parallel roles in regulating organization of the 
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ECM within multiple developmental contexts.  In future investigations, it will be 
interesting to determine precisely how Tmem2 regulates organization of these 
additional ECM components.  Perhaps these findings could reveal alternative 
molecular mechanisms of Tmem2 that may be critical to its other 
developmental roles. 
 With that possibility in mind, we find it intriguing that the R267H variant 
of Tmem2 does not rescue AVC expansion in Ztmem2 mutants but is 
adequately functional to rescue cardiac fusion in MZtmem2 mutants.  Cell 
culture studies have shown that this amino acid residue is critical for 
degradation of HA (Yamamoto et al., 2017; Yoshida et al., 2013).  One 
interpretation of these results is that the hyaluronidase activity of Tmem2 is 
critical for spatial restriction of the AVC but is not essential for promoting 
cardiac fusion.  If Tmem2 does not influence cardiac fusion through HA 
degradation, what is the mechanism of Tmem2 activity in this context?  
Perhaps Tmem2 influences ECM composition through some other means or 
plays another role entirely.  The possibility that Tmem2 has multiple modes of 
function appears even more probable when we consider work investigating 
KIAA1199, also known as cell migration-inducing and hyaluranon binding 
protein (CEMIP).  Although it is not a transmembrane protein, KIAA1199 is 
otherwise structurally very similar to Tmem2.  KIAA1199 contains a G8, PLT, 
and PL domain as well as three conserved PbH1 repeats (Yoshida et al., 
2013).  Likewise, KIAA1199 has been identified as a hyaluronidase, whose 
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enzymatic activity relies on the corresponding amino acid residue identified as 
essential in Tmem2.  Importantly, KIAA1199 has been shown to have multiple 
mechanisms of activity beyond its role as a hyaluronidase, including activation 
of EGF signaling and regulation of calcium release from the endoplasmic 
reticulum (Evensen et al., 2013; Shostak et al., 2014).  Combined with the 
differential function we observe in Tmem2 variants across developmental 
contexts, the evidence suggests that Tmem2, like KIAA1199, most likely 
functions via multiple modes of activity that are context-dependent. 
We also note that the R267H variant does not localize correctly to the 
plasma membrane.  It may be that the aberrant subcellular localization of 
R267H is what accounts for its inability to restrict AVC differentiation 
effectively.  The studies that have shown the importance of this residue for HA 
degradation (Yamamoto et al., 2017; Yoshida et al., 2013) have not examined 
whether there is a corresponding localization defect, and so it is unclear 
exactly why this altered residue causes the loss of hyaluronidase activity.  
Perhaps altering this residue disrupts key protein interactions that both traffic 
Tmem2 to the plasma membrane and enable it to depolymerize HA.  
Regardless, despite not knowing the precise mechanism by which this key 
residue impacts HA catabolism, our findings suggest that Tmem2 delimits 
differentiation of the AVC through HA regulation.  Further, our findings indicate 
that this is likely not the sole function of Tmem2, and that Tmem2 may act in a 
variety of ways depending upon the developmental context. 
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Overall, our work investigating the role of Tmem2 in cardiac 
morphogenesis yields several key findings.  First, we have gained new insight 
into the physiological relevance of identified protein domains within Tmem2.  
Finally, we have established Tmem2 as an essential regulator of HA in the 
context of AVC patterning, a finding that may prove helpful in elucidating the 
broader pathway of how HA influences early cardiac valve development.  
Although it is interesting to consider the activities of Tmem2 as a key regulator 
of ECM composition during developmental and disease processes, it 
nonetheless remains undefined whether these roles of Tmem2 are conserved 
in mouse and human.  Future examination of the conservation of these roles 
will be important to assess the broader relevance of our findings.    
 
 
  
	  	  
78 
MATERIALS AND METHODS 
 
Zebrafish 
We used the zebrafish strains Tg(7xTCF-Xla.Siam:GFP)ia4 (Moro et al., 2012) 
and tmem2sk38 (Totong et al., 2011).  Ztmem2 mutant embryos were 
generated by intercrossing tmem2sk38 heterozygotes.  MZtmem2 mutant 
embryos were obtained by breeding male tmem2 heterozygotes to chimeric 
female fish with a tmem2sk38 mutant germline, created via germline 
replacement as previously described (Totong et al., 2011).  Ztmem2 and 
MZtmem2 mutants were distinguished from their siblings by morphological 
criteria and by PCR genotyping (Totong et al., 2011).  All zebrafish work 
followed protocols approved by the University of California, San Diego 
Institutional Animal Care and Use Committee (IACUC). 
 
Immunofluorescence  
Whole-mount immunofluorescence was performed as previously described 
(Alexander et al., 1999; Peal et al., 2009), using Rhodamine Phalloidin 
(Invitrogen, R415) and antibodies listed in Table 3.S3.  For visualization of HA 
localization, staining was performed as previously described (Alexander et al., 
1999) using biotinylated hyaluranon-binding protein (HABP) (EMD Millipore, 
Billerica, MA; 1:10) and Streptavidin 488 (Thermo Fisher Scientific, Waltham, 
MA; 1:500).  
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In situ hybridization  
In situ hybridization for myl7 (ZDB-GENE-991019-3) and bmp4 (ZDB-GENE-
980528-2059) was performed as previously described (Yelon et al., 1999). 
 
Injection 
Embryos were injected at the one-cell stage with 150 pg of mRNA encoding 
either full-length tmem2 or tmem2 variants.  For live imaging of subcellular 
localization (Fig. 3.4), embryos were injected at the one-cell stage with only 50 
pg of mRNA.  Capped mRNA was synthesized using the mMessage 
mMachine Sp6 kit (Ambion, Foster City, CA). 
For hyaluronidase treatment, embryos were injected within the 
pericardial sac at 30 hpf with 1 nl (~50 units) of hyaluronidase from 
Streptomyces hyalurolyticus (H1136; Sigma, St. Louis, MO).  PBS was 
injected as a control. 
 
Imaging 
Fluorescent images are maximal intensity projections of confocal 
reconstructions of 0.5 micron thick slices acquired using a 25x water objective 
on a Leica SP5 microscope and analyzed using Imaris software (Bitplane).  
For Fig. 3.4. Z-stacks contain 14 slices each.  For Fig. 3.5. Z-stacks contain 4 
slices each. For Figs. 3.7, 3.S1, and 3.S2, Z-stacks contain between 120-150 
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slices.  Additional images were captured using a Zeiss Axiozoom microscope 
with a Zeiss AxioCam and processed using Zeiss AxioVision and Adobe 
Creative Suite. 
 
Tmem2 constructs 
 
Coding sequences for all constructs, including tmem2 and tmem2 variants, 
were inserted into a pCS2 vector with an in-frame C-terminal Gfp tag.  Variants 
sc-tmem2, htrc-tmem2, and ΔC-term were generated using standard 
subcloning procedures.  Variants ΔG8, ΔPLT, ΔPbH1, ΔPL, and R267H were 
generated using Gibson Assembly cloning (New England Biolabs, Ipswich, 
MA).  Details of primer sequences used for making constructs are available 
upon request. 
Sc-tmem2 includes the secretory signal sequence (the first 33 amino acids) 
from the zebrafish sonic hedgehog (shh) gene (Ekker et al., 1995), cloned into 
a version of tmem2-gfp (Totong et al., 2011) that is missing the Tmem2 
cytoplasmic and transmembrane domains (amino acids 1-103).  Htrc-tmem2 
includes the cytoplasmic and transmembrane domains of the type II 
transmembrane protein human transferrin receptor (amino acids 1-96) (Jing et 
al., 1990), cloned into a version of sc-tmem2 vector that is missing the shh 
secretory signal sequence.  ΔC-term includes the first 875 amino acids of 
Tmem2, followed by a Gfp tag.  ΔG8 lacks amino acids 122-246 of Tmem2-
Gfp.  ΔPLT lacks amino acids 222-389 of Tmem2-Gfp.  ΔPbH1 lacks amino 
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acids 672-815 of Tmem2-Gfp.  ΔPL lacks amino acids 1239-1327 of Tmem2-
Gfp.  R267H incorporates an arginine to histidine change at residue 267 of 
Tmem2-Gfp.  
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Figure 3.1. Tmem2 variants employed in this study 
We constructed a series of Tmem2-derived variants and examined the ability of each 
to rescue the tmem2 mutant phenotype, relative to the degree of rescue provided by 
expression of a full-length Tmem2-Gfp fusion protein (top), in which Gfp is fused to 
the C-terminus of Tmem2.  Tmem2 is predicted to be a type II transmembrane protein 
and contains a cytoplasmic (C) and transmembrane (TM) domain, a G8 domain, a 
Pander-like Tmem2 (PLT) domain, three conserved parallel beta-helix repeats 
(PbH1), and a Pander-like (PL) domain (Smith et al., 2011; Totong et al., 2011).  The 
Sc-Tmem2 variant replaces the cytoplasmic and transmembrane domains of Tmem2-
Gfp with a secretory signal sequence.  In the Htrc-Tmem2 variant, the cytoplasmic 
and transmembrane domains of Tmem2-Gfp are replaced by the cytoplasmic and 
transmembrane domains of the human transferrin receptor, a type II transmembrane 
protein.  In the ΔC-term variant, a truncated version of Tmem2, missing the portion of 
the C-terminus that would be absent in the protein encoded by the tmem2sk38  mutant 
allele (Totong et al., 2011), is fused to Gfp.  Additional Tmem2 variants include 
deletions of the G8 domain, the PLT domain, the PbH1 repeats, and the PL domain.  
Finally, the R267H variant contains a missense mutation that changes residue 267, 
within the PLT domain, from arginine to histidine. 
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Figure 3.2. Extracellular domains of Tmem2 are critical for proper AVC 
differentiation 
In situ hybridization indicates expression of bmp4 in wild-type (A,C,E) embryos and 
Ztmem2 (B,D,F) mutant siblings at 48 hours post fertilization (hpf); frontal views.  In 
wild-type (wt) embryos, concentrated expression of bmp4 is restricted to the AVC (A, 
arrowheads), whereas bmp4 is more broadly expressed throughout the ventricle in 
Ztmem2 mutants (B, bracket).  Expression of full-length tmem2 can restore the 
concentrated expression of bmp4 in the AVC of Ztmem2 mutants (D, arrowheads, 
Table 1), but does not affect bmp4 expression in wt siblings (C, arrowheads, Table 
3.S1).  As with ΔC-term and all other extracellular domain deletion variants, 
expression of the ΔG8 variant does not affect bmp4 expression in wt embryos (E, 
arrowheads, Table 3.S1) and provides no evident rescue of the bmp4 expression 
pattern in Ztmem2 mutants (F, bracket, Table 3.1). 
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Table 3.1. Rescue of bmp4 expression pattern by expression of tmem2 and 
variants 	  	  
	  	  
Summary of experiments evaluating whether expression of tmem2 or tmem2 variants 
can rescue the bmp4 expression pattern in Ztmem2 mutants.  Genotype (wild-type or 
Ztmem2) and the injected mRNA are listed for each set of embryos.  Phenotypes 
were assessed through in situ hybridization for bmp4, as in Fig. 3.2. Data indicate the 
fraction of embryos displaying expanded bmp4 expression throughout the ventricle 
(as in Fig. 3.2B,F) or restricted bmp4 expression, concentrated within the AVC (as in 
Fig. 3.2A,C,D,E).  Full-length tmem2 and htrc-tmem2 can rescue the bmp4 
expression pattern in Ztmem2 mutants.  The sc-tmem2 variant can also rescue the 
bmp4 expression pattern, albeit less efficiently than tmem2 and htrc-tmem2.  
(Significant differences from uninjected Ztmem2 were calculated using Fisher’s exact 
test; p<0.00001 for tmem2 and htrc-tmem2, p=0.01 for sc-tmem2).  In contrast, the 
ΔC-term, ΔG8, ΔPLT, ΔPbh1, ΔPL, and R267H variants do not provide notable 
rescue of the bmp4 expression pattern defects in Ztmem2 mutants.  For each mRNA, 
wild-type siblings were injected as controls; see Table 3.S1 for these additional data. 
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Figure 3.3. Extracellular domains of Tmem2 are critical for promoting cardiac 
fusion 
In situ hybridization indicates expression of myl7 in Mtmem2 (A,D,G,I) and MZtmem2 
(B,C,E,F,H,J) embryos at 24 hpf; dorsal views, anterior up.  The heart tube 
assembles normally in Mtmem2 embryos by 24 hpf (A).  MZtmem2 mutant siblings, 
however, display either cardia bifida (B) or, less frequently, partial cardiac fusion (C) 
(Table 3.2).  Expression of full-length tmem2 in MZtmem2 mutants can facilitate 
cardiomyocyte movement to the midline (E) and frequently restores heart tube 
formation (F) (Table 3.2).  Expression of htrc-tmem2 in MZtmem2 mutants can also 
rescue their cardiac fusion defects (H, Table 3.2).  As with ΔC-term and all other 
extracellular domain deletion variants, expression of the ΔG8 variant does not rescue 
cardiac fusion in MZtmem2 mutants (J, Table 3.2).  Mtmem2 sibling embryos appear 
unaffected by expression of tmem2 (D) or tmem2 variants (G, I, Table 3.S2). 
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Table 3.2. Rescue of cardiac fusion by expression of tmem2 and variants 
 
 
	  	  
Summary of experiments evaluating whether expression of tmem2 or tmem2 variants 
can rescue the cardiac fusion defects in MZtmem2 mutants.  Genotype (Mtmem2 or 
MZtmem2) and and the injected mRNA are listed for each set of embryos.  
Phenotypes were assessed through in situ hybridization for myl7, as in Fig. 3.3.  
Embryos displaying two distinct, bilateral populations of cardiomyocytes (as in Fig. 
3.3B,J) or two groups of cardiomyocytes joined only at the posterior (as in Fig. 3.3C) 
were categorized as “not fused”.  Embryos displaying a fused ring of cardiomyocytes, 
but not a heart tube, were categorized as “ring” (as in Fig. 3.3E).  Embryos displaying 
a heart tube were categorized as “tube” (as in Fig. 3.3A,D,F,G,H,I).  Data indicate the 
fraction of embryos within each category.  Full-length tmem2, sc-tmem2, htrc-tmem2, 
and R267H can rescue cardiac fusion in MZtmem2 mutants.  (Significant differences 
from uninjected MZtmem2 were calculated using Fisher’s exact test; p<0.001 for 
tmem2, htrc-tmem2, sc-tmem2, and R267H).  In contrast, ΔC-term and the tmem2 
variants lacking either the G8, PLT, PbH1, or PL domains do not provide notable 
rescue of the MZtmem2 cardiac fusion defects.  Expression of tmem2 or tmem2 
variants does not appear to affect cardiac fusion in Mtmem2 siblings; see Table 3.S2 
for these additional data. 	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Figure 3.4. Subcellular localization of tmem2 and tmem2 variants in zebrafish 
blastomeres 
Confocal reconstruction visualizes Gfp localization in a lateral portion of the blastula 
at 4 hpf, following injection with mRNA encoding Tmem2-Gfp (A) or its variants (B-I).  
Both full-length Tmem2 and Htrc-Tmem2 localize to the plasma membrane (A,B).  Sc-
Tmem2 appears to traffic to the extracellular environment (C).  All variants lacking 
extracellular domains display broad cytoplasmic localization (D-H).  R267H does not 
appear to localize to the plasma membrane like full-length Tmem2, nor does it exhibit 
the same broad localization as the variants with deletions of extracellular domains 
deletions.  Instead, R267H seems to localize to particular foci within the cytoplasm (I).  
For tmem2, n=12; for htrc-tmem2, n=11; for sc-tmem2, n=9; for ΔC-term, n=10; for 
ΔG8, n=8; for ΔPLT, n=9; for ΔPbH1, n=10; for ΔPL, n=8; for R267H, n=16. 
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Figure 3.5. Ztmem2 mutants exhibit aberrant HA deposition 
Fluorescence depicts MF20 (red) and HABP (green) localization in wt (A-C) and 
Ztmem2 mutant (D-F) embryos at 48 hpf.  Three-dimensional reconstructions of 
selected optical sections through the ventricle (V) and the atrium (A), showing both 
channels (C,F), red only (B,E) or green only (A,D).  In wt embryos, a thin layer of HA 
is visible throughout the ventricular cardiac jelly with increased concentration within 
the AVC (A, arrowheads).  In contrast, Ztmem2 mutants exhibit grossly increased 
levels of HABP throughout the ventricular cardiac jelly and at the AVC (D, 
arrowheads).   
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Figure 3.6. Hyaluronidase treatment rescues bmp4 expression pattern defects 
in Ztmem2 mutants   
Expression of bmp4 in wt (A, C) and Ztmem2 (B, D) mutant embryos at 48 hpf, as in 
Fig. 3.2.  Pericardial injections of PBS do not disrupt the bmp4 expression pattern in 
wt (A) or Ztmem2 mutant (B) embryos; compare to Fig. 3.2A,B.  In contrast, 
pericardial injection of hyaluronidase rescues the concentrated expression of bmp4 in 
the AVC of a majority of Ztmem2 mutants (D, arrowheads, Table 3.3), but does not 
affect the bmp4 expression pattern in the majority of wt siblings (C, arrowheads, 
Table 3.3).  
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Table 3.3. Rescue of bmp4 expression pattern by hyaluronidase treatment 
 
 
 
 
 
Summary of experiments evaluating whether hylauronidase treatment can rescue the 
bmp4 expression pattern in Ztmem2 mutants.  Genotype (wild-type or Ztmem2) and 
the material injected are listed for each set of embryos.  Phenotypes were assessed 
through in situ hybridization for bmp4, as in Figs. 3.2 and 3.6 and in Table 3.1.  Data 
indicate the fraction of embryos displaying expanded bmp4 expression throughout the 
ventricle (as in Fig. 3.6B) or restricted bmp4 expression, concentrated within the AVC 
(as in Fig. 3.6A,C,D).  Hyaluronidase treatment is able to efficiently rescue the bmp4 
expression pattern in Ztmem2 mutants (Significant difference from uninjected 
Ztmem2 was calculated using Fisher’s exact test; p<0.00001). 
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Figure 3.7. Hyaluronidase treatment rescues distribution of Wnt signaling in 
Ztmem2 mutants  
Immunofluorescence depicts localization of Dm-grasp (red) and Gfp (green), driven 
by the Wnt signaling reporterTg(7xTCF:GFP) (Moro et al., 2012), in wt (A,B,E,F) and 
Ztmem2 (C,D,G,H) mutant embryos at 48 hpf.  Images shown are three-dimensional 
reconstructions showing both channels (A,C,E,G) or green only (B,D,F,H).  In PBS-
injected wt embryos (A,B), Wnt signaling activity is restricted to the AVC (bracket in 
B).  In PBS-injected Ztmem2 mutants (C,D), the distribution of Wnt signaling activity is 
expanded beyond its normal restriction (bracket in D).  Hyaluronidase treatment 
restricts the distribution of Wnt signaling activity in the majority of Ztmem2 mutants 
(G, bracket in H, Table 3.4), but does not affect the Wnt signaling distribution in most 
wt siblings (E, bracket in F, Table 3.4). 
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Table 3.4. Rescue of Wnt signaling distribution by hyaluronidase treatment 
 
 
 
 
 
Summary of experiments evaluating whether hylauronidase treatment can rescue the 
restriction of Wnt signaling activity in Ztmem2 mutants.  Genotype (wild-type or 
Ztmem2) and the material injected are listed for each set of embryos.  Phenotypes 
were assessed through immunofluorescence for Dm-grasp and Gfp, as in Fig. 3.7.  
Data indicate the fraction of embryos displaying expanded Wnt reporter expression 
(as in Fig. 3.7D) or restricted Wnt reporter expression (as in Fig. 3.7B,F,H).  
Hyaluronidase treatment is able to efficiently restrict the distribution of Wnt signaling 
activity in Ztmem2 mutants.  (Significant difference from uninjected Ztmem2 was 
calculated using Fisher’s exact test; p=0.006). 
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Figure 3.8. The R267H variant fails to restore AVC restriction in Zmem2 
mutants, but efficiently rescues cardiac fusion in MZtmem2 mutants  
Expression of bmp4 in wt (A) and Ztmem2 (B) mutant embryos, as in Fig. 3.2.  
Expression of R267H does not rescue the bmp4 expression pattern in Ztmem2 
embryos (B, bracket, Table 3.1) and does not affect the bmp4 expression pattern in 
wt siblings (A, arrowheads, Table 3.S1); compare to wt and Ztmem2 embryos shown 
in Fig. 3.2A,B.  Expression of myl7 in Mtmem2 (C) and MZtmem2 (D) embryos at 24 
hpf, as in Fig. 3.3.  Expression of R267H efficiently rescues cardiac fusion defects in 
MZtmem2 mutants (D, Table 2) (Significant difference from uninjected MZtmem2 was 
calculated using Fisher’s exact test; p<0.001 for R267H), but does not seem to alter 
cardiac fusion in Mtmem2 siblings (C, Table 3.S2); compared to wt and MZtmem2 
embryos shown in Fig. 3.3A,B. 
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Table 3.S1. Rescue of bmp4 expression pattern by expression of tmem2 and 
variants 
 
 
 
This table restates all of the data from Table 3.1, with the additional inclusion of data 
from wild-type sibling embryos injected with each mRNA. 
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Table 3.S2. Rescue of cardiac fusion by expression of tmem2 and variants 
 
 
 
This table restates all of the data from Table 3.2, with the additional inclusion of data 
from Mtmem2 sibling embryos injected with each mRNA. 
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Figure 3.S1. Rescue of muscle fiber attachment by expression of tmem2 and 
variants 
(A-F) Immunofluorescence depicts muscle fiber organization, using phalloidin (red) to 
recognize both fast and slow muscle fibers and F59 (green) to recognize slow fibers; 
lateral views with dorsal up at 26 hpf.  Somite morphology of Mtmem2 siblings is 
indistinguishable from wild-type embryos, whereas MZtmem2 mutants display muscle 
fiber detachment (Ryckebusch et al., 2016).  Expression of full-length tmem2 
improves the MZtmem2 phenotype (Ryckebusch et al., 2016).  MZtmem2 mutants 
overexpressing ΔPLT still display muscle fiber detachment (D-F), whereas Mtmem2 
siblings overexpressing ΔPLT exhibit normal fiber attachment (A-C).  (G) Bar graph 
compares average prevalence of fiber attachment in somites at 26 hpf; error bars 
indicate s.e.m.  For each embryo, we examined the left side of the myotome.  F59+ 
fibers were counted in each of 10 somites of multiple embryos.  Asterisks indicate 
significant differences from un-injected MZtmem2.  Full-length tmem2, sc-tmem2, ΔC-
term, ΔG8, ΔPL provide significant rescue of muscle fiber attachment in MZtmem2 
mutants.  (Student’s t-test; p<0.0001 for tmem2, p=0.0056 for sc-tmem2, p=0.0014 for 
ΔC-term, p=0.0234 for ΔG8, p=0.0235 for ΔPL).  Although the percent of attached 
fibers in MZtmem2 embryos expressing ΔC-term, ΔG8, ΔPL is significantly higher 
than in uninjected MZtmem2 mutants, it is also significantly different than the 
efficiency of rescue seen with full-length tmem2.  In contrast, ΔPLT and ΔPbH1 
expression does not appear to rescue muscle fiber attachment in MZtmem2 embryos.  
Finally, expression of tmem2 and tmem2 variants does not appear to affect wild-type 
siblings.  This graph re-states published data on sc-tmem2 data (also referred to as 
“ectodomain”) (Ryckebusch et al., 2016).  For Mtmem2, n=4; for MZtmem2, n=7; for 
Mtmem2 expressing tmem2, n=6; for MZtmem2 expressing tmem2, n=8; for Mtmem2 
expressing sc-tmem2, n=2; for MZtmem2 expressing sc-tmem2, n=5; for Mtmem2 
expressing ΔC-term, n=3; for MZtmem2 expressing ΔC-term, n=5; for Mtmem2 
expressing ΔG8, n=4; for MZtmem2 expressing ΔG8, n=5; for Mtmem2 expressing 
ΔPLT, n=4; for MZtmem2 expressing ΔPLT, n=7; for Mtmem2 expressing ΔPbH1, 
n=3; for MZtmem2 expressing ΔPbH1, n=4; for Mtmem2 expressing ΔPL, n=2; for 
MZtmem2 expressing ΔPL, n=5.  
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Figure 3.S2. Chondroitin sulfate localization is expanded in Ztmem2 mutants 
Immunofluorescence depicts localization of Dm-grasp (red) and chondroitin sulfate 
(CS, green) in wild-type (wt) (A-C) and Ztmem2 mutant (D-F) hearts at 50 hpf.  
Images shown are three-dimensional reconstructions showing red only (A,D), green 
only (B,E), or both channels (C,F).  In wt hearts, CS deposition is concentrated within 
the AVC (B).  In contrast, Ztmem2 mutants display broad and heightened CS 
localization throughout the ventricle (E).  
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Table 3.S3. Antibodies used for immunofluorescence 
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A modified version of Chapter 3 will be submitted for publication 
(Hernandez, Lydia; Ryckebüsch, Lucile; Wang, Carole; Ling, Rachel; Yelon, 
Deborah. “Tmem2 restricts atrioventricular canal differentiation by regulating 
degradation of hyaluronic acid”).  Lydia Hernandez is the primary 
researcher/author on this paper.  Lydia Hernandez will be the first author of 
this manuscript and she contributed to designing the experiments, conducting 
research, interpreting results, and writing the manuscript presented in Chapter 
3.  Lucile Ryckebüsch contributed to designing the experiments, conducting 
research, interpreting results, and writing the manuscript presented in Chapter 
3.  Deborah Yelon contributed to designing the experiments, interpreting 
results, and writing the manuscript presented in Chapter 3.  Carole Wang and 
Rachel Ling designed and created plasmid constructs used in Chapter 3. 
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Chapter 4: Future directions toward understanding mechanisms of 
extracellular matrix regulation during cardiac development 
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In this thesis, we have shown that Tmem2 influences the deposition 
and composition of the extracellular matrix (ECM) during both cardiac and 
skeletal muscle development.  Moreover, our results suggest that the 
coordination of ECM organization by Tmem2 is instrumental for the stability of 
muscle fiber attachments, for facilitating cardiomyocyte movement, and for the 
restriction of AVC differentiation.  In addition, our findings indicate that these 
functions of Tmem2 rely upon the four identified domains contained within its 
extracellular portion.  Together, these data reiterate the importance of the 
extracellular milieu during cardiac and muscle morphogenesis.  At the same 
time, it is clear that many open questions related to this topic remain to be 
examined.  In this chapter, I will discuss several key areas for future 
investigations that will expand our understanding of the dynamic interactions 
between cells and their environment during embryonic cardiogenesis.  For 
instance, what is the precise mechanism for HA regulation by Tmem2?  
Following this, how exactly does the ECM inform cardiac development?  Then, 
if Tmem2 has multiple modes of activity during development, what could these 
alternative activities be and what protein interactions are involved?  Finally, I 
will discuss the broader significance of our work regarding Tmem2. 
 
How does Tmem2 regulate hyaluronic acid turnover? 
Several studies have shown that the appropriate pattern of HA 
deposition is required in order to correctly regulate differentiation of the AVC.  
	  	  
102 
Excess HA deposition results in ectopic AVC differentiation outside of its 
normal boundaries, whereas decreased levels of HA inhibit endocardial 
cushion formation within the AVC (Camenisch et al., 2000; Lagendijk et al., 
2011; Walsh and Stainier, 2001).  In previous work, our lab has demonstrated 
that tmem2 is a key player in restricting AVC differentiation (Totong et al., 
2011).  Moreover, in Chapter 3, we confirmed prior work demonstrating that 
tmem2 mutants exhibit excess HA deposition between the endocardium and 
the myocardium (Smith et al., 2011), indicating a role for Tmem2 in limiting the 
levels of HA in the cardiac jelly.  While our data strongly support a model 
whereby Tmem2 restricts AVC differentiation via regulation of HA, the precise 
mechanism by which Tmem2 influences the amount of HA remains unknown.  
Does Tmem2 influence HA levels directly, indirectly, or through some 
combination of approaches?   
tmem2 mutants display expanded has2 expression (Smith et al., 2011; 
Totong et al., 2011) that presumably results in excess HA synthesis.  Thus, it 
is possible that Tmem2 could exert its influence on HA at the transcriptional 
level, upstream of has2 expression.  Very recent work, however, has identified 
Tmem2 as a hyaluronidase.  When transfected with tmem2 cDNA, HEK293 
cells gained the ability to degrade HA from ~1500 kDa down to ~5 kDa 
molecules (Yamamoto et al., 2017).  It is not clear, however, whether this 
activity of Tmem2 is physiologically relevant within the developing embryo.   
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Additional recent work investigating the role of Tmem2 in angiogenesis 
supports the notion that Tmem2 hyaluronidase activity is important for its 
function.  Zebrafish tmem2 mutants exhibit decreased intersegmental vessel 
(ISV) sprouting and increased HA levels surrounding ISVs (De Angelis et al., 
2017).  Injection of tmem2 embryos with hyaluronidase degrades HA and 
improves angiogenesis.  Thus, these results suggest that Tmem2 could 
indeed function through degrading HA in vivo.   
While our data also support the hypothesis that Tmem2 works through 
depolymerization of HA, it remains unclear whether Tmem2 directly binds HA.  
KIAA199, a protein that is structurally very similar to Tmem2, has been shown 
to bind HA directly in cell culture (Yoshida et al., 2013).  However, work 
investigating the ability of Tmem2 to promote HA degradation does not 
examine whether Tmem2 interacts directly with HA molecules (Yamamoto et 
al., 2017).  Rather than depolymerize HA itself, it is still plausible that Tmem2 
could induce the activity of other known hyaluronidases or matrix 
metalloproteinases (MMPs) in order to coordinate HA catabolism.  In the 
future, it will be valuable to determine the precise physical nature of Tmem2-
HA interaction through biochemical approaches in embryonic tissue. 
If Tmem2 acts as a hyaluronidase in vivo, then we might imagine that 
overexpression of tmem2 would result in deficient endocardial cushion 
formation, given that that embryos deficient in HA do not form endocardial 
cushions (Camenisch et al., 2000; Walsh and Stainier, 2001).  We note, 
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however, that overexpression of tmem2 in wild-type embryos does not appear 
to result in any noticeable defects in AVC differentiation (Totong et al., 2011) 
(Fig. 3.2B; Table 3.1).  Considering how strictly the HA pathway is controlled, 
perhaps there are co-factors required for Tmem2 hyaluronidase function that 
serve to limit its activity.  Clearly, additional work investigating the exact way in 
which Tmem2 regulates HA and what additional factors modulate Tmem2 
activity will be beneficial in broadening our awareness of how the ECM is 
organized. 
 
How does HA affect AVC formation? 
It is understood that HA levels are tightly regulated and that this 
regulation plays a critical role in AVC development (Toole, 2004; Valiente-
Alandi et al., 2016).  What remains unknown is the precise way in which matrix 
composition informs cell behavior.  How does HA deposition influence the 
differentiation of myocardial and endocardial cells in the AVC?  One possibility 
is that HA size and deposition impact signaling by influencing the activity of 
various signaling pathways (De Angelis et al., 2017; Itano, 2008; Jiang et al., 
2005; Termeer et al., 2002).  For example, in the AVC of mice, HA activates 
phosphorylation of ErbB2 and ErbB3 heterodimers (Camenisch et al., 2000), 
an interaction critical for endocardial cushion formation (Erickson et al., 1997).  
Phosphorylation of these heterodimers induces the activity of β-catenin and 
downstream effectors of the Wnt signaling pathway (Bourguignon et al., 2007).  
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As described in Chapter 1, Wnt-driven β-catenin translocation is essential for 
endocardial cushion development (Hurlstone et al., 2003; Liebner et al., 2004).  
In addition, β-catenin activity also influences has2 expression patterns 
(Hurlstone et al., 2003).  This positive feedback loop of HA regulation is one 
striking example by which HA can impact both its own expression as well as 
signaling pathways that are crucial for AVC differentiation.  
Additional work has shown the impact of low molecular weight HA 
fragments, also referred to as o-HA, on the VEGF signaling pathway.  In 
forming endocardial cushions, endocardial cells at the AVC undergo an 
epithelial to mesenchymal transition (EMT).  In avian studies, it has been 
demonstrated that o-HAs, inhibit EMT by activating VEGF signaling, an 
antagonist of EMT (Chang et al., 2004; Rodgers et al., 2006).  
Research in zebrafish tmem2 mutants also examined the impact of o-
HA in the context of angiogenesis (De Angelis et al., 2017).  As described 
above, tmem2 mutants exhibit intersegmental vessel (ISV) sprouting defects 
that were ameliorated by depolymerization of HA.  Intriguingly, treatment of 
tmem2 mutants with exogenous o-HA also ameliorated their ISV sprouting 
defects (De Angelis et al., 2017).  Thus, these findings suggest that HA 
fragment size, rather than HA levels, is a key component to angiogenesis.   
Is HA fragment size similarly important for the regulation of AVC 
differentiation?  To test this, we could perform a similar experiment and treat 
tmem2 mutants with exogenous o-HA at 30 hpf.  If we see rescue of the 
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restriction of AVC differentiation, then this would suggest that the role of 
Tmem2 in this context is to generate HA molecules of a specific size.  On the 
other hand, if introduction of o-HAs fails to rescue AVC defects in tmem2 
mutants, we might conclude that Tmem2 regulation of HA levels or distribution 
could be more critical for the spatial restriction of AVC differentiation. 
Nonetheless, it is entirely possible that multiple mechanisms of HA 
activity overlap to instruct AVC development.  Understanding the full picture of 
the timing and mechanism of HA function would be beneficial to create a more 
thorough understanding of the processes that coordinate cell behavior during 
cardiac morphogenesis.  
 
Does Tmem2 promote cardiac fusion through regulation of HA? 
Early cardiac morphogenesis requires cardiomyocytes to move toward 
the embryonic midline, where they merge to give rise to the primitive heart 
tube (Bussmann et al., 2007; Holtzman et al., 2007; Moreno-Rodriguez et al., 
2006; Schoenebeck and Yelon, 2007) (Fig 1.1), a process referred to as 
cardiac fusion.  In zebrafish embryos lacking both maternal and zygotic 
sources of tmem2 (MZtmem2), cardiomyocytes do not migrate medially and 
cardiac fusion does not occur (Ryckebusch et al., 2016; Totong et al., 2011) 
(Fig. 1.3B).  In Chapters 2 and 3, we identified regions of the Tmem2 protein 
that are essential for its function in promoting cardiomyocyte migration.  The 
reason why cardiac fusion fails in MZtmem2 mutants, however, remains poorly 
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understood.  Both correct endodermal specification and ECM composition are 
essential for cardiac fusion to occur (Arrington and Yost, 2009; Garavito-
Aguilar et al., 2010; Holtzman et al., 2007; Kikuchi et al., 2001; Kupperman et 
al., 2000; Trinh and Stainier, 2004).  However, our lab has observed normal 
endodermal specification and morphogenesis in MZtmem2 mutant embryos 
(data not shown).  Given that MZtmem2 mutants exhibit aberrant ECM 
organization and deposition in multiple tissues (Ryckebusch et al., 2016), it 
seems probable that defective ECM composition could underlie the inhibition 
of cardiac fusion in these embryos.  What are the requirements for ECM 
composition during cardiac fusion and does Tmem2 coordinate these 
conditions?     
Our findings suggest that Tmem2 functions to delimit AVC 
differentiation through regulation of HA.  Is regulation of HA by Tmem2 also 
essential for its function in promoting cardiac fusion?  A first step in addressing 
this question would be to determine whether HA is present in the matrix that 
surrounds migrating cardiomyocytes during cardiac fusion.  If HA is indeed 
present within this extracellular milieu, we could then examine whether 
MZtmem2 mutants exhibit aberrant HA deposition.  Based upon what we have 
observed in zygotic tmem2 mutant hearts (Fig. 3.5D-F), we might observe 
similarly excessive HA deposition in MZtmem2 mutants.  If we detect aberrant 
HA deposition, we can then test whether modulating HA levels in MZtmem2 
mutants rescues their cardiac fusion defects.  If we find that HA degradation 
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rescues cardiomyocyte mobility in MZtmem2 mutants, then these results 
would suggest a role for Tmem2 regulation of HA in this earlier developmental 
context.  It is possible, however, that HA may not be a critical component of 
the ECM during this particular process.  Alternatively, we may determine that 
HA is a component of the ECM that mediates cardiac fusion, but that HA 
remains appropriately deposited around the cardiomyocytes in MZtmem2 
mutants.  Either of these results would suggest that the MZtmem2 fusion 
defect is most likely not a consequence of erroneous HA turnover.   
Although we cannot currently rule out HA as a key player in cardiac 
fusion, our findings to date do not support this model.  R267H, the Tmem2 
variant lacking hyaluronidase activity, is not able to rescue the tmem2 mutant 
AVC restriction defect.  In sharp contrast, this same variant seems fully 
functional in the context of cardiac fusion.  Over-expression of R267H in 
MZtmem2 mutants rescues cardiac fusion as effectively as full-length Tmem2 
does (Fig. 3.8D) (Table 3.2).  If we take the interpretation that the main 
functional defect of R267H is its inability to degrade HA, then we can surmise 
from these results that AVC restriction relies on depolymerization of HA by 
Tmem2, whereas cardiac fusion does not.  However, as described in Chapter 
3, R267H does not localize correctly to the plasma membrane (Fig. 3.4).  
Perhaps, as an alternative interpretation, the principal functional defect of 
R267H is that it simply can’t traffic efficiently to the membrane.  It could be that 
higher levels of Tmem2 protein are required for AVC differentiation than for 
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cardiac fusion and that there simply isn’t enough R267H present at the 
membrane to function effectively.  We could test this by increasing the level of 
R267H overexpression and assessing whether this improves the mutant AVC 
defects.  We have performed a similar experiment where we doubled 
overexpression levels of the secreted Tmem2 ectodomain (Sc-tmem2).  
However, we failed to see any improvement in tmem2 mutant AVC restriction.  
Thus, we might also see that increasing R267H overexpression similarly fails 
to rescue AVC differentiation.  Alternatively, we could investigate how 
localization of Tmem2 affects function.  To do this, we could attempt to create 
a version of R267H that is anchored to the outside of the plasma membrane - 
possibly via the addition of a glycosylphosphatidylinositol (GPI) linker - and 
assess its ability to rescue mutant AVC differentiation.  In future studies, it will 
be essential to learn exactly why the R267H variant is not functional in AVC 
differentiation.  By doing this, we will gain a clearer understanding of the 
physical mechanism of Tmem2 activity. 
However, regardless of the precise reason for why R267H fails to 
rescue AVC expansion, its ability to rescue cardiac fusion defects in MZtmem2 
mutants strongly indicates that Tmem2 has multiple mechanisms of action.  
Assuming that Tmem2 restricts AVC differentiation by regulating HA 
depolymerization, the following question remains: how does Tmem2 promote 
cardiac fusion? 
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What could be additional mechanisms of Tmem2 activity? 
One potential way for Tmem2 to promote cardiac fusion could be 
through the regulation of other ECM components besides HA.  It is known that 
correct composition of the ECM is required for cardiac fusion to occur 
(Arrington and Yost, 2009; Trinh and Stainier, 2004; Trinh et al., 2005) and our 
laboratory’s analyses of hand2 mutants have shown that an excess of Fn can 
inhibit cardiomyocyte movement (Garavito-Aguilar et al., 2010) (Fig. 1.2D).  
Given this, we were curious to see whether the cardiac extracellular 
environment was disorganized in MZtmem2 mutants.  Whereas Mtmem2 
embryos display a normal pattern of polarized Fn deposition adjacent to the 
myocardium (Fig. 2.3D’), we observe abnormally abundant and disorganized 
Fn deposition around the MZtmem2 mutant cardiomyocytes (Fig. 2.3E’).  
Strikingly, we find that the abnormal localization of Fn in MZtmem2 mutants is 
reminiscent of the hand2 mutant phenotype (Fig. 1.2B).  Therefore, we 
hypothesized that excessive ECM deposition may be responsible for the cell 
movement defects seen in MZtmem2 mutants.  
We initially tested this hypothesis by observing whether alteration of the 
MZtmem2 mutant ECM can rescue cardiac fusion.  Genetic reduction of Fn 
was achieved by breeding female chimeras with tmem2 mutant germlines 
(Ciruna et al., 2002; Totong et al., 2011) to males heterozygous for both 
tmem2 and natter (nat), a mutation in fn1 (Trinh and Stainier, 2004).  
Interestingly, we found partial rescue of cardiac fusion in 13 out of 29 
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MZtmem2 embryos that were heterozygous for the nat mutation. (data not 
shown).  Although decreasing Fn levels helped ameliorate MZtmem2 cardiac 
fusion defects, it did not efficiently rescue them.  These findings raise 
interesting questions about what underlies the partial rescue in this scenario.   
Certainly, it is possible that reducing the levels of any single ECM 
component might not be adequate for complete rescue of cardiac fusion, 
especially if Tmem2 regulates multiple ECM components simultaneously.  One 
way to address this issue would be through more comprehensive modification 
of the ECM, such as using two or more mutations to modulate levels of 
multiple ECM components simultaneously.  Another possibility is that the 
defects in the MZtmem2 mutant ECM relate more to its precise organization 
rather than simply to excess deposition.  To begin to test this, we compared 
amounts of Fn present in embryonic lysate from MZtmem2 mutants and from 
their wild-type siblings.  Despite the observed disorganization of Fn deposition 
seen in MZtmem2 mutants, they did not exhibit globally increased levels of Fn 
(data not shown).  These preliminary data support the idea that Tmem2 
functions within the context of cardiac fusion to coordinate the precise 
organization of Fn rather than as an upstream regulator of Fn production. In 
future studies, it will be helpful to confirm and extend these studies to examine 
the affect of Tmem2 on Fn and other ECM components during cardiac fusion.  
Excitingly, the Holley lab has created a transgenic zebrafish line that allows for 
live fluorescent imaging of Fn (Julich et al., 2015).  Emerging tools like these 
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could help us move toward a better understanding of Fn organization and 
temporal dynamics during development. 
Currently, it remains unclear precisely how Tmem2 impacts the ECM 
and whether ECM organization is the sole mechanism by which Tmem2 
promotes cardiac fusion.  Moving forward, it is helpful to consider the most 
likely models of Tmem2 function in this context.  One possibility, as discussed 
above, is that Tmem2 could act primarily to govern ECM deposition and 
organization.  Alternatively, Tmem2 could interact with upstream signaling 
pathways to promote cardiac fusion.  
 
Does Tmem2 influence the EGF signaling pathway? 
In selecting which pathways to investigate, we have become interested 
in considering the pathways that involve KIAA1199.  KIAA1199 is structurally 
very similar to Tmem2; it contains a G8 domain, PbH1 repeats, and two 
Pander-like domains (Yoshida et al., 2013).  Further, like Tmem2, KIAA1199 
has been shown to depolymerize HA.  However, KIAA1199 also has additional 
modes of activity.  For example, studies of KIAA1199 have revealed an 
association between its G8 domain and the EGF receptor (EGFR) that 
activates downstream EGF signaling and promotes migration of cancer cells 
(Shostak et al., 2014).  Because of the structural and functional similarities 
between KIAA1199 and Tmem2, we hypothesized that perhaps Tmem2 could 
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likewise bind EGFR and activate EGF signaling as a means of promoting 
cardiomyocyte migration during fusion.  Our preliminary data, however, do not 
support this hypothesis.  For example, we have found that chemical inhibition 
of EGF signaling does not hinder cardiac fusion (data not shown).  
Additionally, pulldowns of Tmem2-Gfp from transfected HEK cell lysate did not 
reveal a protein interaction between EGFR and Tmem2.  Although these are 
only preliminary results, they do not support the hypothesis that Tmem2 
functions through EGFR binding or activation of EGFR specifically.   
It is possible that Tmem2 could activate EGF signaling in some 
alternative, indirect way.  It is also plausible, however, that Tmem2 does not 
function to activate EGF signaling and, instead, influences a different signaling 
pathway entirely.  Therefore, it would be valuable for us to extend our work to 
include the analysis of additional pathways known to influence cell movement.  
One potential pathway to examine is the non-canonical Wnt signaling 
pathway.  Importantly, non-canonical Wnts have been shown to modulate cell 
movement during development and cardiogenesis (McEwen and Peifer, 2000; 
Pandur et al., 2002).  For instance, in Xenopus, morpholino knockdown of the 
non-canonical Wnt ligand, Wnt11R, induces defects in heart tube fusion 
(Garriock et al., 2005).  Alongside testing whether Tmem2 is involved with 
candidate pathways such as non-canonical Wnt signaling, another strategy for 
identifying alternative pathways to investigate is to determine Tmem2 protein 
binding partners. 
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What proteins does Tmem2 interact with? 
To better understand the mechanisms of Tmem2 activity, we aim to 
identify which proteins Tmem2 interacts with in a functionally relevant context.  
In order to identify relevant potential Tmem2 protein interactors, our goal was 
to compare which proteins complex with full-length Tmem2 versus non-
functional Tmem2 variants.  Given that the functionality of specific Tmem2 
variants is context-dependent, this approach could also potentially reveal 
context-dependent protein interactions.  To achieve this, we transiently 
transfected HEK293T cells with Tmem2 and Tmem2 variant cDNA, 
immunoprecipitated Tmem2 from cell lysate, and submitted these samples for 
mass spectrometry analysis in collaboration with the Briggs Lab.  
Pilot studies did not indicate any obviously compelling candidate 
proteins that interact with Tmem2.  Further, our pulldown samples yielded 
single-digit spectral counts for nearly all identified proteins except Tmem2, 
limiting our ability to prioritize which candidates to investigate.  This may be 
due to several factors.  First, the procedural conditions for the pulldowns may 
not be optimized for the types of interactions we hope to uncover.  Second, it 
is entirely plausible that we are performing these pulldowns in cells that don’t 
provide the proper biochemical environment for Tmem2 function.   
To achieve our goal of identifying Tmem2 protein interactors, it may be 
beneficial to do these analyses in either cardiac or muscle cell lines or, ideally, 
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in zebrafish embryos.  Once the optimal conditions for Tmem2 pulldowns are 
established, it would be exciting to compare which proteins complex with full-
length Tmem2 versus which proteins complex with the R267H variant.  This 
particular experiment has the potential to provide novel information about the 
differential roles of Tmem2 across cardiac morphogenesis.  Overall, 
determining Tmem2 binding partners is likely to provide valuable insight into 
Tmem2 activity, ECM regulation, and the pathways involved in cardiac 
morphogenesis. 
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What is the broader significance of this work? 
 Within the field of developmental biology, we are becoming more aware 
of the extensive impact that the ECM has on cell behavior during 
morphogenesis.  Overall, our data provide valuable insight into Tmem2 
function and support a model whereby Tmem2 coordinates cardiac and 
skeletal muscle morphogenesis through regulation of the ECM.  While it is 
intriguing to consider how the orchestration of matrix by Tmem2 influences 
early development, it is still unknown how conserved these mechanisms of 
Tmem2 function are across species.  In future studies, it will be beneficial to 
confirm and extend these findings in mammalian model systems.   
Additionally, there remain many intriguing open questions regarding the 
role of the ECM in cardiac development, some of which I have discussed in 
this chapter.  A more comprehensive understanding of Tmem2 activity will be 
instrumental to our grasp of the nature of ECM regulation as well as the 
interplay between matrix and developing organ systems.  Ultimately, these 
insights will increase our comprehension of how cell behavior is coordinated 
during organogenesis and how the boundaries of tissue differentiation are 
established and maintained in the developing embryo.   
  Moreover, continuing investigation of Tmem2 has the potential to yield 
therapeutic strategies to address congenital heart disease as well as muscular 
dystrophies.  Additionally, we stand to enhance our understanding of cell 
movement, a process that is frequently aberrant in a variety of diseases.  
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Overall, our work investigating the role of Tmem2 has the potential to enrich 
our awareness of the multiple processes, pathways, and physical cues that 
overlap to dictate embryonic development and disease. 
 
Preliminary experiments described in Chapter 4 were designed and 
performed primarily by Lydia Hernandez.  Lucile Ryckebüsch performed 
genetic reduction of Fn in MZtmem2 mutants.  Parthiv Sheth assisted with cell 
culture transfections and western blots.  Arjana Pradhan and Prae 
Pongtornpipat examined pharmacological inhibition of EGFR in zebrafish 
embryos.  Mass spectrometry analysis of Tmem2 immunoprecipitate was 
performed in collaboration with Zhouxin Shen of the Briggs laboratory.  
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